exlc_randomization;usubjid;exclpopulations;excl1pop;excl2pop;excl3pop;exclreason1;exclreason2;exclreason3
BNT162b2 (30 μg);C4591001 1006 10061272;Dose 2 all-available efficacy Evaluable efficacy (7 days) ;Dose 2 all-available efficacy ;;Evaluable efficacy (7 days) ;Did not receive 2 vaccinations;"  Randomized but did not meet all eligibility criteria; did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1)";
BNT162b2 (30 μg);C4591001 1007 10071409;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1007 10071622;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1007 10071642;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1044 10441359;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 1057 10571396;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 1057 10571413;Dose 1 all-available efficacy Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 1 all-available efficacy ;Dose 2 all-available efficacy ;Evaluable efficacy (7 days);Did not receive at least 1 vaccination;  Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1)
BNT162b2 (30 μg);C4591001 1066 10661407;Evaluable efficacy (7 days)  ;;;Evaluable efficacy (7 days)  ;Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);  ;
BNT162b2 (30 μg);C4591001 1091 10911414;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1091 10911451;Dose 1 all-available efficacy Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 1 all-available efficacy ;Dose 2 all-available efficacy ;Evaluable efficacy (7 days);Did not receive at least 1 vaccination;  Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1)
BNT162b2 (30 μg);C4591001 1139 11391261;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Unblinded prior to 7 days post Dose 2;  Unblinded prior to 7 days post Dose 2; 
BNT162b2 (30 μg);C4591001 1140 11401346;Dose 1 all-available efficacy Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 1 all-available efficacy ;Dose 2 all-available efficacy ;Evaluable efficacy (7 days);Did not receive at least 1 vaccination;  Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1)
BNT162b2 (30 μg);C4591001 1142 11421363;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 1147 11471327;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1152 11521641;Dose 2 all-available efficacy Evaluable efficacy (7 days)  ;Dose 2 all-available efficacy ;;Evaluable efficacy (7 days)  ;Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);  
BNT162b2 (30 μg);C4591001 1001 10011125;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1003 10031143;Dose 1 all-available efficacy Dose 2 all-available efficacy Evaluable efficacy (7 days) ;Dose 1 all-available efficacy ;Dose 2 all-available efficacy ;Evaluable efficacy (7 days) ;Did not receive at least 1 vaccination;  Did not receive 2 vaccinations;"  Randomized but did not meet all eligibility criteria; did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1)"
BNT162b2 (30 μg);C4591001 1005 10051381;Dose 1 all-available efficacy Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 1 all-available efficacy ;Dose 2 all-available efficacy ;Evaluable efficacy (7 days);Did not receive at least 1 vaccination;  Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1)
BNT162b2 (30 μg);C4591001 1005 10051411;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Unblinded prior to 7 days post Dose 2;  Unblinded prior to 7 days post Dose 2; 
BNT162b2 (30 μg);C4591001 1008 10081492;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 1008 10081529;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1011 10111039;Evaluable efficacy (7 days)  ;;;Evaluable efficacy (7 days)  ;Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);  ;
BNT162b2 (30 μg);C4591001 1012 10121001;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1012 10121103;Evaluable efficacy (7 days)  ;;;Evaluable efficacy (7 days)  ;"Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1); had other important protocol deviations on or prior to 7 days after Dose 2";;
BNT162b2 (30 μg);C4591001 1012 10121163;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1013 10131138;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1013 10131544;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 1013 10131670;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1013 10131834;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 1015 10151199;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1016 10161047;Dose 2 all-available efficacy   Evaluable efficacy (7 days);Dose 2 all-available efficacy   ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;    Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1016 10161087;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1016 10161341;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1018 10181025;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1018 10181028;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 1018 10181054;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1018 10181142;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1018 10181165;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 1018 10181186;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 1018 10181266;Dose 2 all-available efficacy   Evaluable efficacy (7 days);Dose 2 all-available efficacy   ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;    Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1018 10181310;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1018 10181311;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1019 10191166;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1019 10191254;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 1024 10241002;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Had other important protocol deviations on or prior to 7 days after Dose 2;;
BNT162b2 (30 μg);C4591001 1024 10241004;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Had other important protocol deviations on or prior to 7 days after Dose 2;;
BNT162b2 (30 μg);C4591001 1024 10241006;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Had other important protocol deviations on or prior to 7 days after Dose 2;;
BNT162b2 (30 μg);C4591001 1024 10241014;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Had other important protocol deviations on or prior to 7 days after Dose 2;;
BNT162b2 (30 μg);C4591001 1024 10241023;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Had other important protocol deviations on or prior to 7 days after Dose 2;;
BNT162b2 (30 μg);C4591001 1024 10241032;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Had other important protocol deviations on or prior to 7 days after Dose 2;;
BNT162b2 (30 μg);C4591001 1024 10241033;Evaluable efficacy (7 days)  ;;;Evaluable efficacy (7 days)  ;Had other important protocol deviations on or prior to 7 days after Dose 2;  ;
BNT162b2 (30 μg);C4591001 1024 10241039;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Had other important protocol deviations on or prior to 7 days after Dose 2;;
BNT162b2 (30 μg);C4591001 1024 10241040;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Had other important protocol deviations on or prior to 7 days after Dose 2;;
BNT162b2 (30 μg);C4591001 1024 10241042;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Had other important protocol deviations on or prior to 7 days after Dose 2;;
BNT162b2 (30 μg);C4591001 1024 10241044;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Had other important protocol deviations on or prior to 7 days after Dose 2;;
BNT162b2 (30 μg);C4591001 1024 10241046;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Had other important protocol deviations on or prior to 7 days after Dose 2;;
BNT162b2 (30 μg);C4591001 1024 10241054;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Had other important protocol deviations on or prior to 7 days after Dose 2;;
BNT162b2 (30 μg);C4591001 1024 10241055;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Had other important protocol deviations on or prior to 7 days after Dose 2;;
BNT162b2 (30 μg);C4591001 1024 10241061;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Had other important protocol deviations on or prior to 7 days after Dose 2;;
BNT162b2 (30 μg);C4591001 1024 10241066;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Had other important protocol deviations on or prior to 7 days after Dose 2;;
BNT162b2 (30 μg);C4591001 1024 10241067;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Had other important protocol deviations on or prior to 7 days after Dose 2;;
BNT162b2 (30 μg);C4591001 1024 10241071;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Had other important protocol deviations on or prior to 7 days after Dose 2;;
BNT162b2 (30 μg);C4591001 1024 10241072;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Had other important protocol deviations on or prior to 7 days after Dose 2;;
BNT162b2 (30 μg);C4591001 1024 10241074;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Had other important protocol deviations on or prior to 7 days after Dose 2;;
BNT162b2 (30 μg);C4591001 1024 10241078;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Had other important protocol deviations on or prior to 7 days after Dose 2;;
BNT162b2 (30 μg);C4591001 1024 10241084;Evaluable efficacy (7 days)  ;;;Evaluable efficacy (7 days)  ;Had other important protocol deviations on or prior to 7 days after Dose 2;  ;
BNT162b2 (30 μg);C4591001 1024 10241085;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Had other important protocol deviations on or prior to 7 days after Dose 2;;
BNT162b2 (30 μg);C4591001 1024 10241091;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Had other important protocol deviations on or prior to 7 days after Dose 2;;
BNT162b2 (30 μg);C4591001 1024 10241094;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Had other important protocol deviations on or prior to 7 days after Dose 2;;
BNT162b2 (30 μg);C4591001 1024 10241100;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Had other important protocol deviations on or prior to 7 days after Dose 2;;
BNT162b2 (30 μg);C4591001 1024 10241102;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Had other important protocol deviations on or prior to 7 days after Dose 2;;
BNT162b2 (30 μg);C4591001 1024 10241104;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Had other important protocol deviations on or prior to 7 days after Dose 2;;
BNT162b2 (30 μg);C4591001 1024 10241108;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Had other important protocol deviations on or prior to 7 days after Dose 2;;
BNT162b2 (30 μg);C4591001 1028 10281072;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1028 10281267;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 1036 10361011;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1036 10361050;Dose 1 all-available efficacy Dose 2 all-available efficacy   Evaluable efficacy (7 days) ;Dose 1 all-available efficacy ;Dose 2 all-available efficacy   ;Evaluable efficacy (7 days) ;Did not receive at least 1 vaccination;  Did not receive 2 vaccinations;"    Randomized but did not meet all eligibility criteria; did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1)"
BNT162b2 (30 μg);C4591001 1036 10361127;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1036 10361135;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 1037 10371068;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1037 10371078;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1038 10381061;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Had other important protocol deviations on or prior to 7 days after Dose 2;;
BNT162b2 (30 μg);C4591001 1042 10421069;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1042 10421251;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1044 10441001;Evaluable efficacy (7 days)  ;;;Evaluable efficacy (7 days)  ;Had other important protocol deviations on or prior to 7 days after Dose 2;  ;
BNT162b2 (30 μg);C4591001 1044 10441015;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Had other important protocol deviations on or prior to 7 days after Dose 2;;
BNT162b2 (30 μg);C4591001 1044 10441028;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Had other important protocol deviations on or prior to 7 days after Dose 2;;
BNT162b2 (30 μg);C4591001 1044 10441029;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Had other important protocol deviations on or prior to 7 days after Dose 2;;
BNT162b2 (30 μg);C4591001 1044 10441031;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Had other important protocol deviations on or prior to 7 days after Dose 2;;
BNT162b2 (30 μg);C4591001 1044 10441034;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Had other important protocol deviations on or prior to 7 days after Dose 2;;
BNT162b2 (30 μg);C4591001 1044 10441037;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Had other important protocol deviations on or prior to 7 days after Dose 2;;
BNT162b2 (30 μg);C4591001 1044 10441045;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Had other important protocol deviations on or prior to 7 days after Dose 2;;
BNT162b2 (30 μg);C4591001 1044 10441048;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Had other important protocol deviations on or prior to 7 days after Dose 2;;
BNT162b2 (30 μg);C4591001 1044 10441050;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Had other important protocol deviations on or prior to 7 days after Dose 2;;
BNT162b2 (30 μg);C4591001 1044 10441052;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Had other important protocol deviations on or prior to 7 days after Dose 2;;
BNT162b2 (30 μg);C4591001 1044 10441054;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Had other important protocol deviations on or prior to 7 days after Dose 2;;
BNT162b2 (30 μg);C4591001 1044 10441060;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Had other important protocol deviations on or prior to 7 days after Dose 2;;
BNT162b2 (30 μg);C4591001 1044 10441063;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Had other important protocol deviations on or prior to 7 days after Dose 2;;
BNT162b2 (30 μg);C4591001 1044 10441068;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Had other important protocol deviations on or prior to 7 days after Dose 2;;
BNT162b2 (30 μg);C4591001 1044 10441071;Evaluable efficacy (7 days)  ;;;Evaluable efficacy (7 days)  ;Had other important protocol deviations on or prior to 7 days after Dose 2;  ;
BNT162b2 (30 μg);C4591001 1044 10441076;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Had other important protocol deviations on or prior to 7 days after Dose 2;;
BNT162b2 (30 μg);C4591001 1044 10441079;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Had other important protocol deviations on or prior to 7 days after Dose 2;;
BNT162b2 (30 μg);C4591001 1044 10441088;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Had other important protocol deviations on or prior to 7 days after Dose 2;;
BNT162b2 (30 μg);C4591001 1044 10441089;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Had other important protocol deviations on or prior to 7 days after Dose 2;;
BNT162b2 (30 μg);C4591001 1044 10441272;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Unblinded prior to 7 days post Dose 2;  Unblinded prior to 7 days post Dose 2; 
BNT162b2 (30 μg);C4591001 1046 10461285;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 1046 10461348;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 1052 10521064;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1052 10521080;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1052 10521139;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1052 10521143;Evaluable efficacy (7 days)  ;;;Evaluable efficacy (7 days)  ;Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);  ;
BNT162b2 (30 μg);C4591001 1054 10541022;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1054 10541033;Dose 2 all-available efficacy Evaluable efficacy (7 days) ;Dose 2 all-available efficacy ;;Evaluable efficacy (7 days) ;Did not receive 2 vaccinations;"  Randomized but did not meet all eligibility criteria; did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1)";
BNT162b2 (30 μg);C4591001 1054 10541055;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1054 10541064;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1054 10541138;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1056 10561013;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 1056 10561027;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1056 10561097;Evaluable efficacy (7 days)  ;;;Evaluable efficacy (7 days)  ;Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);  ;
BNT162b2 (30 μg);C4591001 1056 10561146;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 1056 10561193;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 1056 10561195;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 1056 10561271;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 1056 10561293;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1056 10561300;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 1056 10561316;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 1056 10561317;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 1056 10561352;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 1056 10561361;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1056 10561402;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 1056 10561452;Dose 2 all-available efficacy Evaluable efficacy (7 days)  ;Dose 2 all-available efficacy ;;Evaluable efficacy (7 days)  ;Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);  
BNT162b2 (30 μg);C4591001 1056 10561516;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1056 10561550;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1056 10561569;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1056 10561576;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 1056 10561579;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 1056 10561643;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 1057 10571129;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 1057 10571212;Dose 1 all-available efficacy Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 1 all-available efficacy ;Dose 2 all-available efficacy ;Evaluable efficacy (7 days);Did not receive at least 1 vaccination;  Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1)
BNT162b2 (30 μg);C4591001 1057 10571279;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 1057 10571331;Evaluable efficacy (7 days)  ;;;Evaluable efficacy (7 days)  ;Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);  ;
BNT162b2 (30 μg);C4591001 1066 10661198;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1066 10661203;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 1066 10661321;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 1066 10661332;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1066 10661335;Dose 1 all-available efficacy Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 1 all-available efficacy ;Dose 2 all-available efficacy ;Evaluable efficacy (7 days);Did not receive at least 1 vaccination;  Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1)
BNT162b2 (30 μg);C4591001 1066 10661406;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 1068 10681002;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Had other important protocol deviations on or prior to 7 days after Dose 2;;
BNT162b2 (30 μg);C4591001 1068 10681006;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Had other important protocol deviations on or prior to 7 days after Dose 2;;
BNT162b2 (30 μg);C4591001 1068 10681011;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Had other important protocol deviations on or prior to 7 days after Dose 2;;
BNT162b2 (30 μg);C4591001 1068 10681016;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Had other important protocol deviations on or prior to 7 days after Dose 2;;
BNT162b2 (30 μg);C4591001 1068 10681021;Evaluable efficacy (7 days)  ;;;Evaluable efficacy (7 days)  ;Had other important protocol deviations on or prior to 7 days after Dose 2;  ;
BNT162b2 (30 μg);C4591001 1068 10681024;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Had other important protocol deviations on or prior to 7 days after Dose 2;;
BNT162b2 (30 μg);C4591001 1068 10681027;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Had other important protocol deviations on or prior to 7 days after Dose 2;;
BNT162b2 (30 μg);C4591001 1068 10681034;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Had other important protocol deviations on or prior to 7 days after Dose 2;;
BNT162b2 (30 μg);C4591001 1068 10681035;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Had other important protocol deviations on or prior to 7 days after Dose 2;;
BNT162b2 (30 μg);C4591001 1068 10681042;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Had other important protocol deviations on or prior to 7 days after Dose 2;;
BNT162b2 (30 μg);C4591001 1068 10681046;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Had other important protocol deviations on or prior to 7 days after Dose 2;;
BNT162b2 (30 μg);C4591001 1068 10681053;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Had other important protocol deviations on or prior to 7 days after Dose 2;;
BNT162b2 (30 μg);C4591001 1068 10681058;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Had other important protocol deviations on or prior to 7 days after Dose 2;;
BNT162b2 (30 μg);C4591001 1068 10681060;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Had other important protocol deviations on or prior to 7 days after Dose 2;;
BNT162b2 (30 μg);C4591001 1068 10681061;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Had other important protocol deviations on or prior to 7 days after Dose 2;;
BNT162b2 (30 μg);C4591001 1068 10681072;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Had other important protocol deviations on or prior to 7 days after Dose 2;;
BNT162b2 (30 μg);C4591001 1068 10681073;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Had other important protocol deviations on or prior to 7 days after Dose 2;;
BNT162b2 (30 μg);C4591001 1068 10681077;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Had other important protocol deviations on or prior to 7 days after Dose 2;;
BNT162b2 (30 μg);C4591001 1068 10681081;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Had other important protocol deviations on or prior to 7 days after Dose 2;;
BNT162b2 (30 μg);C4591001 1071 10711008;Evaluable efficacy (7 days)  ;;;Evaluable efficacy (7 days)  ;Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);  ;
BNT162b2 (30 μg);C4591001 1071 10711095;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1071 10711235;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1073 10731038;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1079 10791004;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1079 10791058;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 1079 10791079;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 1079 10791135;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 1079 10791252;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 1081 10811071;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1081 10811105;Dose 1 all-available efficacy   Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 1 all-available efficacy   ;Dose 2 all-available efficacy ;Evaluable efficacy (7 days);Did not receive at least 1 vaccination;    Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1)
BNT162b2 (30 μg);C4591001 1082 10821078;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1083 10831141;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1083 10831152;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 1083 10831197;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 1084 10841035;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1084 10841118;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 1084 10841272;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1085 10851245;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 1085 10851332;Dose 2 all-available efficacy   Evaluable efficacy (7 days);Dose 2 all-available efficacy   ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;    Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1087 10871209;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1087 10871336;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1087 10871557;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1087 10871562;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1088 10881045;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 1088 10881077;Evaluable efficacy (7 days)  ;;;Evaluable efficacy (7 days)  ;"Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1); had other important protocol deviations on or prior to 7 days after Dose 2";;
BNT162b2 (30 μg);C4591001 1089 10891158;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1089 10891182;Dose 2 all-available efficacy   Evaluable efficacy (7 days);Dose 2 all-available efficacy   ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;    Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1089 10891311;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 1089 10891346;Dose 1 all-available efficacy Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 1 all-available efficacy ;Dose 2 all-available efficacy ;Evaluable efficacy (7 days);Did not receive at least 1 vaccination;  Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1)
BNT162b2 (30 μg);C4591001 1089 10891351;Dose 1 all-available efficacy Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 1 all-available efficacy ;Dose 2 all-available efficacy ;Evaluable efficacy (7 days);Did not receive at least 1 vaccination;  Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1)
BNT162b2 (30 μg);C4591001 1090 10901136;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 1090 10901510;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 1091 10911005;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Had other important protocol deviations on or prior to 7 days after Dose 2;;
BNT162b2 (30 μg);C4591001 1091 10911008;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Had other important protocol deviations on or prior to 7 days after Dose 2;;
BNT162b2 (30 μg);C4591001 1091 10911015;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Had other important protocol deviations on or prior to 7 days after Dose 2;;
BNT162b2 (30 μg);C4591001 1091 10911039;Dose 2 all-available efficacy Evaluable efficacy (7 days)  ;Dose 2 all-available efficacy ;;Evaluable efficacy (7 days)  ;Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);  
BNT162b2 (30 μg);C4591001 1091 10911077;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1091 10911130;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 1091 10911232;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 1091 10911358;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 1091 10911387;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1092 10921128;Dose 1 all-available efficacy Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 1 all-available efficacy ;Dose 2 all-available efficacy ;Evaluable efficacy (7 days);Did not receive at least 1 vaccination;  Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1)
BNT162b2 (30 μg);C4591001 1092 10921249;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1093 10931055;Dose 1 all-available efficacy Dose 2 all-available efficacy   Evaluable efficacy (7 days) ;Dose 1 all-available efficacy ;Dose 2 all-available efficacy   ;Evaluable efficacy (7 days) ;Did not receive at least 1 vaccination;  Did not receive 2 vaccinations;"    Randomized but did not meet all eligibility criteria; did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1)"
BNT162b2 (30 μg);C4591001 1093 10931058;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1093 10931065;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1093 10931211;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1095 10951110;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1095 10951124;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 1095 10951141;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1095 10951168;Dose 2 all-available efficacy Evaluable efficacy (7 days)  ;Dose 2 all-available efficacy ;;Evaluable efficacy (7 days)  ;Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);  
BNT162b2 (30 μg);C4591001 1095 10951173;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1095 10951208;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 1096 10961141;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1096 10961197;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Had other important protocol deviations on or prior to 7 days after Dose 2;;
BNT162b2 (30 μg);C4591001 1096 10961287;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 1096 10961288;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 1096 10961344;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1098 10981029;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1098 10981169;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);"Randomized but did not meet all eligibility criteria; had other important protocol deviations on or prior to 7 days after Dose 2";;
BNT162b2 (30 μg);C4591001 1098 10981189;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 1098 10981200;Dose 2 all-available efficacy   Evaluable efficacy (7 days);Dose 2 all-available efficacy   ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;    Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1101 11011021;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 1107 11071018;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 1107 11071162;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 1109 11091059;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1109 11091234;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1109 11091349;Dose 1 all-available efficacy Dose 2 all-available efficacy Evaluable efficacy (7 days) ;Dose 1 all-available efficacy ;Dose 2 all-available efficacy ;Evaluable efficacy (7 days) ;Did not receive at least 1 vaccination;  Did not receive 2 vaccinations;"  Randomized but did not meet all eligibility criteria; did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1)"
BNT162b2 (30 μg);C4591001 1109 11091391;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 1109 11091406;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 1109 11091414;Evaluable efficacy (7 days)  ;;;Evaluable efficacy (7 days)  ;Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);  ;
BNT162b2 (30 μg);C4591001 1109 11091417;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 1109 11091422;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 1109 11091522;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 1110 11101006;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1110 11101039;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1110 11101069;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1110 11101154;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1110 11101333;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1111 11111064;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 1111 11111099;Dose 2 all-available efficacy   Evaluable efficacy (7 days);Dose 2 all-available efficacy   ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;    Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1111 11111105;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 1112 11121058;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1112 11121101;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 1112 11121192;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1112 11121229;Dose 1 all-available efficacy Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 1 all-available efficacy ;Dose 2 all-available efficacy ;Evaluable efficacy (7 days);Did not receive at least 1 vaccination;  Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1)
BNT162b2 (30 μg);C4591001 1112 11121270;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1114 11141037;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1116 11161015;Dose 1 all-available efficacy   Dose 2 all-available efficacy Evaluable efficacy (7 days) ;Dose 1 all-available efficacy   ;Dose 2 all-available efficacy ;Evaluable efficacy (7 days) ;Did not receive at least 1 vaccination;    Did not receive 2 vaccinations;"  Randomized but did not meet all eligibility criteria; did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1)"
BNT162b2 (30 μg);C4591001 1116 11161143;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1116 11161172;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1116 11161226;Evaluable efficacy (7 days)  ;;;Evaluable efficacy (7 days)  ;"Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1); had other important protocol deviations on or prior to 7 days after Dose 2";;
BNT162b2 (30 μg);C4591001 1117 11171070;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 1121 11211025;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1122 11221026;Dose 1 all-available efficacy Dose 2 all-available efficacy Evaluable efficacy (7 days)  ;Dose 1 all-available efficacy ;Dose 2 all-available efficacy ;Evaluable efficacy (7 days)  ;Did not receive at least 1 vaccination;  Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1)
BNT162b2 (30 μg);C4591001 1123 11231027;Dose 1 all-available efficacy Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 1 all-available efficacy ;Dose 2 all-available efficacy ;Evaluable efficacy (7 days);Did not receive at least 1 vaccination;  Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1)
BNT162b2 (30 μg);C4591001 1123 11231144;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1123 11231154;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1123 11231168;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1123 11231208;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 1123 11231263;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 1123 11231301;Dose 1 all-available efficacy Dose 2 all-available efficacy Evaluable efficacy (7 days)   ;Dose 1 all-available efficacy ;Dose 2 all-available efficacy ;Evaluable efficacy (7 days)   ;Did not receive at least 1 vaccination;  Did not receive 2 vaccinations;"  Randomized but did not meet all eligibility criteria; did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1)"
BNT162b2 (30 μg);C4591001 1123 11231386;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1124 11241049;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1124 11241100;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 1125 11251148;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1125 11251159;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1125 11251243;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1126 11261053;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Had other important protocol deviations on or prior to 7 days after Dose 2;;
BNT162b2 (30 μg);C4591001 1127 11271022;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1128 11281126;Evaluable efficacy (7 days)  ;;;Evaluable efficacy (7 days)  ;Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);  ;
BNT162b2 (30 μg);C4591001 1129 11291061;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 1129 11291238;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 1129 11291249;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1131 11311024;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1133 11331052;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1133 11331122;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1133 11331295;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1133 11331316;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 1133 11331341;Dose 2 all-available efficacy Evaluable efficacy (7 days)  ;Dose 2 all-available efficacy ;;Evaluable efficacy (7 days)  ;Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);  
BNT162b2 (30 μg);C4591001 1133 11331346;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 1133 11331509;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1134 11341033;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1134 11341153;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1134 11341174;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1134 11341177;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 1134 11341228;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 1135 11351061;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1135 11351199;Dose 2 all-available efficacy Evaluable efficacy (7 days)  ;Dose 2 all-available efficacy ;;Evaluable efficacy (7 days)  ;Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);  
BNT162b2 (30 μg);C4591001 1135 11351389;Dose 1 all-available efficacy Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 1 all-available efficacy ;Dose 2 all-available efficacy ;Evaluable efficacy (7 days);Did not receive at least 1 vaccination;  Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1)
BNT162b2 (30 μg);C4591001 1135 11351428;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1135 11351430;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1135 11351523;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1136 11361043;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1136 11361108;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 1136 11361111;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1140 11401301;Dose 2 all-available efficacy   Evaluable efficacy (7 days);Dose 2 all-available efficacy   ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;    Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1141 11411011;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Had other important protocol deviations on or prior to 7 days after Dose 2;;
BNT162b2 (30 μg);C4591001 1141 11411014;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Had other important protocol deviations on or prior to 7 days after Dose 2;;
BNT162b2 (30 μg);C4591001 1141 11411023;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Had other important protocol deviations on or prior to 7 days after Dose 2;;
BNT162b2 (30 μg);C4591001 1141 11411065;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Had other important protocol deviations on or prior to 7 days after Dose 2;;
BNT162b2 (30 μg);C4591001 1141 11411096;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 1141 11411127;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 1141 11411164;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1141 11411166;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 1141 11411179;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 1141 11411249;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 1146 11461010;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 1147 11471212;Dose 2 all-available efficacy Evaluable efficacy (7 days)  ;Dose 2 all-available efficacy ;;Evaluable efficacy (7 days)  ;Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);  
BNT162b2 (30 μg);C4591001 1149 11491005;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1149 11491031;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1149 11491067;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1149 11491088;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 1149 11491209;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 1152 11521034;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1152 11521477;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 1156 11561006;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1157 11571070;Dose 2 all-available efficacy Evaluable efficacy (7 days)  ;Dose 2 all-available efficacy ;;Evaluable efficacy (7 days)  ;Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);  
BNT162b2 (30 μg);C4591001 1157 11571169;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 1161 11611001;Dose 1 all-available efficacy Dose 2 all-available efficacy Evaluable efficacy (7 days)   ;Dose 1 all-available efficacy ;Dose 2 all-available efficacy ;Evaluable efficacy (7 days)   ;Data considered potentially unreliable due to lack of PI oversight identified as significant quality event; Data considered potentially unreliable due to lack of PI oversight identified as significant quality event;" Data considered potentially unreliable due to lack of PI oversight identified as significant quality event; did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1); had other important protocol deviations on or prior to 7 days after Dose 2"
BNT162b2 (30 μg);C4591001 1161 11611002;Dose 1 all-available efficacy Dose 2 all-available efficacy  Evaluable efficacy (7 days)   ;Dose 1 all-available efficacy ;Dose 2 all-available efficacy  ;Evaluable efficacy (7 days)   ;Data considered potentially unreliable due to lack of PI oversight identified as significant quality event;" Did not receive 2 vaccinations; data considered potentially unreliable due to lack of PI oversight identified as significant quality event";" Randomized but did not meet all eligibility criteria; data considered potentially unreliable due to lack of PI oversight identified as significant quality event; did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1)"
BNT162b2 (30 μg);C4591001 1161 11611006;Dose 1 all-available efficacy Dose 2 all-available efficacy  Evaluable efficacy (7 days)    ;Dose 1 all-available efficacy ;Dose 2 all-available efficacy  ;Evaluable efficacy (7 days)    ;Data considered potentially unreliable due to lack of PI oversight identified as significant quality event;" Did not receive 2 vaccinations; data considered potentially unreliable due to lack of PI oversight identified as significant quality event";" Data considered potentially unreliable due to lack of PI oversight identified as significant quality event; did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1)"
BNT162b2 (30 μg);C4591001 1161 11611009;Dose 1 all-available efficacy Dose 2 all-available efficacy Evaluable efficacy (7 days)   ;Dose 1 all-available efficacy ;Dose 2 all-available efficacy ;Evaluable efficacy (7 days)   ;Data considered potentially unreliable due to lack of PI oversight identified as significant quality event; Data considered potentially unreliable due to lack of PI oversight identified as significant quality event;" Data considered potentially unreliable due to lack of PI oversight identified as significant quality event; did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1); had other important protocol deviations on or prior to 7 days after Dose 2"
BNT162b2 (30 μg);C4591001 1161 11611011;Dose 1 all-available efficacy Dose 2 all-available efficacy Evaluable efficacy (7 days)    ;Dose 1 all-available efficacy ;Dose 2 all-available efficacy ;Evaluable efficacy (7 days)    ;Data considered potentially unreliable due to lack of PI oversight identified as significant quality event; Data considered potentially unreliable due to lack of PI oversight identified as significant quality event;" Randomized but did not meet all eligibility criteria; data considered potentially unreliable due to lack of PI oversight identified as significant quality event; did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1); had other important protocol deviations on or prior to 7 days after Dose 2"
BNT162b2 (30 μg);C4591001 1161 11611014;Dose 1 all-available efficacy Dose 2 all-available efficacy Evaluable efficacy (7 days)    ;Dose 1 all-available efficacy ;Dose 2 all-available efficacy ;Evaluable efficacy (7 days)    ;Data considered potentially unreliable due to lack of PI oversight identified as significant quality event; Data considered potentially unreliable due to lack of PI oversight identified as significant quality event;" Randomized but did not meet all eligibility criteria; data considered potentially unreliable due to lack of PI oversight identified as significant quality event; did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1); had other important protocol deviations on or prior to 7 days after Dose 2"
BNT162b2 (30 μg);C4591001 1161 11611017;Dose 1 all-available efficacy   Dose 2 all-available efficacy Evaluable efficacy (7 days)   ;Dose 1 all-available efficacy   ;Dose 2 all-available efficacy ;Evaluable efficacy (7 days)   ;Data considered potentially unreliable due to lack of PI oversight identified as significant quality event;   Data considered potentially unreliable due to lack of PI oversight identified as significant quality event;" Data considered potentially unreliable due to lack of PI oversight identified as significant quality event; did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1); had other important protocol deviations on or prior to 7 days after Dose 2"
BNT162b2 (30 μg);C4591001 1161 11611019;Dose 1 all-available efficacy Dose 2 all-available efficacy Evaluable efficacy (7 days)   ;Dose 1 all-available efficacy ;Dose 2 all-available efficacy ;Evaluable efficacy (7 days)   ;Data considered potentially unreliable due to lack of PI oversight identified as significant quality event; Data considered potentially unreliable due to lack of PI oversight identified as significant quality event;" Data considered potentially unreliable due to lack of PI oversight identified as significant quality event; did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1); had other important protocol deviations on or prior to 7 days after Dose 2"
BNT162b2 (30 μg);C4591001 1161 11611020;Dose 1 all-available efficacy Dose 2 all-available efficacy Evaluable efficacy (7 days)   ;Dose 1 all-available efficacy ;Dose 2 all-available efficacy ;Evaluable efficacy (7 days)   ;Data considered potentially unreliable due to lack of PI oversight identified as significant quality event; Data considered potentially unreliable due to lack of PI oversight identified as significant quality event;" Data considered potentially unreliable due to lack of PI oversight identified as significant quality event; did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1); had other important protocol deviations on or prior to 7 days after Dose 2"
BNT162b2 (30 μg);C4591001 1161 11611026;Dose 1 all-available efficacy Dose 2 all-available efficacy Evaluable efficacy (7 days)     ;Dose 1 all-available efficacy ;Dose 2 all-available efficacy ;Evaluable efficacy (7 days)     ;Data considered potentially unreliable due to lack of PI oversight identified as significant quality event; Data considered potentially unreliable due to lack of PI oversight identified as significant quality event;" Data considered potentially unreliable due to lack of PI oversight identified as significant quality event; did not receive all   vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1); had other important protocol deviations on or prior to 7 days after Dose 2"
BNT162b2 (30 μg);C4591001 1161 11611032;Dose 1 all-available efficacy Dose 2 all-available efficacy Evaluable efficacy (7 days)   ;Dose 1 all-available efficacy ;Dose 2 all-available efficacy ;Evaluable efficacy (7 days)   ;Data considered potentially unreliable due to lack of PI oversight identified as significant quality event; Data considered potentially unreliable due to lack of PI oversight identified as significant quality event;" Data considered potentially unreliable due to lack of PI oversight identified as significant quality event; did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1); had other important protocol deviations on or prior to 7 days after Dose 2"
BNT162b2 (30 μg);C4591001 1161 11611034;Dose 1 all-available efficacy Dose 2 all-available efficacy Evaluable efficacy (7 days)   ;Dose 1 all-available efficacy ;Dose 2 all-available efficacy ;Evaluable efficacy (7 days)   ;Data considered potentially unreliable due to lack of PI oversight identified as significant quality event; Data considered potentially unreliable due to lack of PI oversight identified as significant quality event;" Data considered potentially unreliable due to lack of PI oversight identified as significant quality event; did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1); had other important protocol deviations on or prior to 7 days after Dose 2"
BNT162b2 (30 μg);C4591001 1161 11611041;Dose 1 all-available efficacy Dose 2 all-available efficacy Evaluable efficacy (7 days)     ;Dose 1 all-available efficacy ;Dose 2 all-available efficacy ;Evaluable efficacy (7 days)     ;Data considered potentially unreliable due to lack of PI oversight identified as significant quality event; Data considered potentially unreliable due to lack of PI oversight identified as significant quality event;" Data considered potentially unreliable due to lack of PI oversight identified as significant quality event; did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1); had other important protocol deviations on or prior to 7 days after Dose 2"
BNT162b2 (30 μg);C4591001 1162 11621005;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1162 11621118;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1162 11621128;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Had other important protocol deviations on or prior to 7 days after Dose 2;;
BNT162b2 (30 μg);C4591001 1162 11621374;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1162 11621381;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1162 11621391;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1162 11621477;Dose 1 all-available efficacy Dose 2 all-available efficacy Evaluable efficacy (7 days)   ;Dose 1 all-available efficacy ;Dose 2 all-available efficacy ;Evaluable efficacy (7 days)   ;Did not receive at least 1 vaccination;  Did not receive 2 vaccinations;"  Randomized but did not meet all eligibility criteria; did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1)"
BNT162b2 (30 μg);C4591001 1162 11621524;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1162 11621566;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1163 11631006;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1163 11631069;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1163 11631117;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Had other important protocol deviations on or prior to 7 days after Dose 2;;
BNT162b2 (30 μg);C4591001 1163 11631121;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Had other important protocol deviations on or prior to 7 days after Dose 2;;
BNT162b2 (30 μg);C4591001 1163 11631124;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Had other important protocol deviations on or prior to 7 days after Dose 2;;
BNT162b2 (30 μg);C4591001 1163 11631127;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Had other important protocol deviations on or prior to 7 days after Dose 2;;
BNT162b2 (30 μg);C4591001 1163 11631136;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Had other important protocol deviations on or prior to 7 days after Dose 2;;
BNT162b2 (30 μg);C4591001 1163 11631142;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Had other important protocol deviations on or prior to 7 days after Dose 2;;
BNT162b2 (30 μg);C4591001 1163 11631145;Evaluable efficacy (7 days)  ;;;Evaluable efficacy (7 days)  ;Had other important protocol deviations on or prior to 7 days after Dose 2;  ;
BNT162b2 (30 μg);C4591001 1167 11671111;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1168 11681030;Dose 1 all-available efficacy Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 1 all-available efficacy ;Dose 2 all-available efficacy ;Evaluable efficacy (7 days);Did not receive at least 1 vaccination;  Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1)
BNT162b2 (30 μg);C4591001 1169 11691049;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Had other important protocol deviations on or prior to 7 days after Dose 2;;
BNT162b2 (30 μg);C4591001 1170 11701023;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 1170 11701112;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 1170 11701205;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 1170 11701300;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 1170 11701316;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 1170 11701365;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);"Randomized but did not meet all eligibility criteria; had other important protocol deviations on or prior to 7 days after Dose 2";;
BNT162b2 (30 μg);C4591001 1170 11701422;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 1170 11701435;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 1170 11701441;Evaluable efficacy (7 days)  ;;;Evaluable efficacy (7 days)  ;Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);  ;
BNT162b2 (30 μg);C4591001 1170 11701450;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 1170 11701451;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 1170 11701452;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 1170 11701457;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Had other important protocol deviations on or prior to 7 days after Dose 2;;
BNT162b2 (30 μg);C4591001 1171 11711042;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1171 11711072;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1171 11711151;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 1171 11711153;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 1171 11711214;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 1171 11711219;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 1171 11711225;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 1171 11711229;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 1171 11711236;Evaluable efficacy (7 days)  ;;;Evaluable efficacy (7 days)  ;Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);  ;
BNT162b2 (30 μg);C4591001 1171 11711242;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 1171 11711249;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 1177 11771491;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 1178 11781061;Evaluable efficacy (7 days)  ;;;Evaluable efficacy (7 days)  ;"Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1); had other important protocol deviations on or prior to 7 days after Dose 2";;
BNT162b2 (30 μg);C4591001 1178 11781107;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1179 11791138;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1194 11941061;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1195 11951055;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 1195 11951061;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1197 11971042;Evaluable efficacy (7 days)  ;;;Evaluable efficacy (7 days)  ;Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);  ;
BNT162b2 (30 μg);C4591001 1197 11971045;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 1203 12031037;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1205 12051028;Dose 1 all-available efficacy Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 1 all-available efficacy ;Dose 2 all-available efficacy ;Evaluable efficacy (7 days);Did not receive at least 1 vaccination;  Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1)
BNT162b2 (30 μg);C4591001 1207 12071024;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1208 12081018;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1209 12091013;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1212 12121023;Dose 1 all-available efficacy Dose 2 all-available efficacy   Evaluable efficacy (7 days) ;Dose 1 all-available efficacy ;Dose 2 all-available efficacy   ;Evaluable efficacy (7 days) ;Did not receive at least 1 vaccination;  Did not receive 2 vaccinations;"    Randomized but did not meet all eligibility criteria; did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1)"
BNT162b2 (30 μg);C4591001 1213 12131012;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Had other important protocol deviations on or prior to 7 days after Dose 2;;
BNT162b2 (30 μg);C4591001 1214 12141016;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 1214 12141036;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1218 12181045;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Unblinded prior to 7 days post Dose 2;  Unblinded prior to 7 days post Dose 2; 
BNT162b2 (30 μg);C4591001 1218 12181046;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Unblinded prior to 7 days post Dose 2;  Unblinded prior to 7 days post Dose 2; 
BNT162b2 (30 μg);C4591001 1218 12181051;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Unblinded prior to 7 days post Dose 2;  Unblinded prior to 7 days post Dose 2; 
BNT162b2 (30 μg);C4591001 1218 12181055;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Unblinded prior to 7 days post Dose 2;  Unblinded prior to 7 days post Dose 2; 
BNT162b2 (30 μg);C4591001 1218 12181059;Dose 2 all-available efficacy   Evaluable efficacy (7 days);Dose 2 all-available efficacy   ;;Evaluable efficacy (7 days);Unblinded prior to 7 days post Dose 2;    Unblinded prior to 7 days post Dose 2; 
BNT162b2 (30 μg);C4591001 1219 12191047;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Unblinded prior to 7 days post Dose 2;  Unblinded prior to 7 days post Dose 2; 
BNT162b2 (30 μg);C4591001 1219 12191054;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Unblinded prior to 7 days post Dose 2;  Unblinded prior to 7 days post Dose 2; 
BNT162b2 (30 μg);C4591001 1220 12201020;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Had other important protocol deviations on or prior to 7 days after Dose 2;;
BNT162b2 (30 μg);C4591001 1220 12201036;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1220 12201059;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Unblinded prior to 7 days post Dose 2;  Unblinded prior to 7 days post Dose 2; 
BNT162b2 (30 μg);C4591001 1220 12201063;Dose 2 all-available efficacy Evaluable efficacy (7 days) ;Dose 2 all-available efficacy ;;Evaluable efficacy (7 days) ;Unblinded prior to 7 days post Dose 2;"  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1); unblinded prior to 7 days post Dose 2";
BNT162b2 (30 μg);C4591001 1221 12211024;Dose 2 all-available efficacy Evaluable efficacy (7 days)  ;Dose 2 all-available efficacy ;;Evaluable efficacy (7 days)  ;Unblinded prior to 7 days post Dose 2;  Unblinded prior to 7 days post Dose 2;   
BNT162b2 (30 μg);C4591001 1221 12211079;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Had other important protocol deviations on or prior to 7 days after Dose 2;;
BNT162b2 (30 μg);C4591001 1223 12231200;Dose 1 all-available efficacy Dose 2 all-available efficacy Evaluable efficacy (7 days) ;Dose 1 all-available efficacy ;Dose 2 all-available efficacy ;Evaluable efficacy (7 days) ;Did not receive at least 1 vaccination;  Did not receive 2 vaccinations;"  Randomized but did not meet all eligibility criteria; did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1)"
BNT162b2 (30 μg);C4591001 1223 12231234;Dose 1 all-available efficacy Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 1 all-available efficacy ;Dose 2 all-available efficacy ;Evaluable efficacy (7 days);Did not receive at least 1 vaccination;  Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1)
BNT162b2 (30 μg);C4591001 1224 12241176;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1226 12261072;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1226 12261114;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 1226 12261409;Dose 2 all-available efficacy Evaluable efficacy (7 days)  ;Dose 2 all-available efficacy ;;Evaluable efficacy (7 days)  ;Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);  
BNT162b2 (30 μg);C4591001 1226 12261797;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 1226 12262136;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 1226 12262229;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 1226 12262255;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Had other important protocol deviations on or prior to 7 days after Dose 2;;
BNT162b2 (30 μg);C4591001 1226 12262262;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 1226 12262313;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1229 12291204;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1230 12301045;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1230 12301099;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 1230 12301113;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1230 12301148;Dose 2 all-available efficacy   Evaluable efficacy (7 days);Dose 2 all-available efficacy   ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;    Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1231 12311027;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 1231 12311125;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1231 12311189;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1231 12311200;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1231 12311409;Dose 1 all-available efficacy Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 1 all-available efficacy ;Dose 2 all-available efficacy ;Evaluable efficacy (7 days);Did not receive at least 1 vaccination;  Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1)
BNT162b2 (30 μg);C4591001 1231 12311443;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1231 12311499;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Had other important protocol deviations on or prior to 7 days after Dose 2;;
BNT162b2 (30 μg);C4591001 1231 12311532;Dose 2 all-available efficacy   Evaluable efficacy (7 days);Dose 2 all-available efficacy   ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;    Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1231 12311641;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1231 12311801;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 1231 12311825;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 1231 12311894;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1231 12311911;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1231 12311991;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1231 12312052;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 1231 12312077;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 1231 12312284;Dose 2 all-available efficacy Evaluable efficacy (7 days)  ;Dose 2 all-available efficacy ;;Evaluable efficacy (7 days)  ;Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);  
BNT162b2 (30 μg);C4591001 1231 12312339;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1231 12312361;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1231 12312365;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1231 12312372;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 1231 12312375;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1231 12312403;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1231 12312435;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 1231 12312451;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1231 12312559;Dose 2 all-available efficacy   Evaluable efficacy (7 days);Dose 2 all-available efficacy   ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;    Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1231 12312577;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1231 12313006;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1231 12313175;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1231 12313207;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1231 12313225;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1231 12313289;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 1231 12313357;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1231 12313428;Dose 2 all-available efficacy   Evaluable efficacy (7 days);Dose 2 all-available efficacy   ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;    Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1231 12313429;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Unblinded prior to 7 days post Dose 2;"  Unblinded prior to 7 days post Dose 2; had other important protocol deviations on or prior to 7 days after Dose 2";
BNT162b2 (30 μg);C4591001 1231 12313449;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1231 12313456;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Unblinded prior to 7 days post Dose 2;"  Unblinded prior to 7 days post Dose 2; had other important protocol deviations on or prior to 7 days after Dose 2";
BNT162b2 (30 μg);C4591001 1231 12313459;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1231 12313467;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1231 12313469;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1231 12313479;Dose 2 all-available efficacy Evaluable efficacy (7 days)  ;Dose 2 all-available efficacy ;;Evaluable efficacy (7 days)  ;Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);  
BNT162b2 (30 μg);C4591001 1231 12313483;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Unblinded prior to 7 days post Dose 2;"  Unblinded prior to 7 days post Dose 2; had other important protocol deviations on or prior to 7 days after Dose 2";
BNT162b2 (30 μg);C4591001 1231 12313486;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1231 12313487;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Unblinded prior to 7 days post Dose 2;"  Unblinded prior to 7 days post Dose 2; had other important protocol deviations on or prior to 7 days after Dose 2";
BNT162b2 (30 μg);C4591001 1231 12313492;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1231 12313497;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1231 12313498;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1231 12313501;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Unblinded prior to 7 days post Dose 2;"  Unblinded prior to 7 days post Dose 2; had other important protocol deviations on or prior to 7 days after Dose 2";
BNT162b2 (30 μg);C4591001 1231 12313505;Dose 2 all-available efficacy   Evaluable efficacy (7 days);Dose 2 all-available efficacy   ;;Evaluable efficacy (7 days);Unblinded prior to 7 days post Dose 2;"    Unblinded prior to 7 days post Dose 2; had other important protocol deviations on or prior to 7 days after Dose 2";
BNT162b2 (30 μg);C4591001 1231 12313506;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1231 12313508;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Unblinded prior to 7 days post Dose 2;"  Unblinded prior to 7 days post Dose 2; had other important protocol deviations on or prior to 7 days after Dose 2";
BNT162b2 (30 μg);C4591001 1231 12313509;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1231 12313512;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1231 12313514;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1231 12313515;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Unblinded prior to 7 days post Dose 2;"  Unblinded prior to 7 days post Dose 2; had other important protocol deviations on or prior to 7 days after Dose 2";
BNT162b2 (30 μg);C4591001 1231 12313517;Dose 2 all-available efficacy Evaluable efficacy (7 days)  ;Dose 2 all-available efficacy ;;Evaluable efficacy (7 days)  ;Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);  
BNT162b2 (30 μg);C4591001 1231 12313518;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1231 12313519;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1231 12313528;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1231 12313533;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Unblinded prior to 7 days post Dose 2;"  Unblinded prior to 7 days post Dose 2; had other important protocol deviations on or prior to 7 days after Dose 2";
BNT162b2 (30 μg);C4591001 1231 12313534;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1231 12313537;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1231 12313541;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1231 12313542;Dose 2 all-available efficacy   Evaluable efficacy (7 days);Dose 2 all-available efficacy   ;;Evaluable efficacy (7 days);Unblinded prior to 7 days post Dose 2;"    Unblinded prior to 7 days post Dose 2; had other important protocol deviations on or prior to 7 days after Dose 2";
BNT162b2 (30 μg);C4591001 1231 12313546;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1231 12313551;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1231 12313553;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Unblinded prior to 7 days post Dose 2;"  Unblinded prior to 7 days post Dose 2; had other important protocol deviations on or prior to 7 days after Dose 2";
BNT162b2 (30 μg);C4591001 1231 12313554;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1231 12313556;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Unblinded prior to 7 days post Dose 2;"  Unblinded prior to 7 days post Dose 2; had other important protocol deviations on or prior to 7 days after Dose 2";
BNT162b2 (30 μg);C4591001 1231 12313564;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Unblinded prior to 7 days post Dose 2;"  Unblinded prior to 7 days post Dose 2; had other important protocol deviations on or prior to 7 days after Dose 2";
BNT162b2 (30 μg);C4591001 1231 12313567;Dose 2 all-available efficacy Evaluable efficacy (7 days)  ;Dose 2 all-available efficacy ;;Evaluable efficacy (7 days)  ;Unblinded prior to 7 days post Dose 2;"  Unblinded prior to 7 days post Dose 2; had other important protocol deviations on or prior to 7 days after Dose 2";  
BNT162b2 (30 μg);C4591001 1231 12313592;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1231 12313622;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1231 12313662;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1231 12313709;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1231 12313869;Dose 1 all-available efficacy Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 1 all-available efficacy ;Dose 2 all-available efficacy ;Evaluable efficacy (7 days);Did not receive at least 1 vaccination;  Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1)
BNT162b2 (30 μg);C4591001 1231 12313892;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 1231 12313967;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 1231 12314179;Dose 2 all-available efficacy Evaluable efficacy (7 days)  ;Dose 2 all-available efficacy ;;Evaluable efficacy (7 days)  ;Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);  
BNT162b2 (30 μg);C4591001 1231 12314205;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1231 12314290;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 1231 12314314;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1231 12314385;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1231 12314416;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 1231 12314502;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 1231 12314525;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 1231 12314580;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1231 12314590;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1231 12314700;Dose 2 all-available efficacy   Evaluable efficacy (7 days);Dose 2 all-available efficacy   ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;    Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1231 12314713;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1231 12315189;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 1231 12315204;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 1231 12315223;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 1231 12315269;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1231 12315308;Dose 1 all-available efficacy Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 1 all-available efficacy ;Dose 2 all-available efficacy ;Evaluable efficacy (7 days);Did not receive at least 1 vaccination;  Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1)
BNT162b2 (30 μg);C4591001 1231 12315429;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1231 12315441;Dose 2 all-available efficacy Evaluable efficacy (7 days)  ;Dose 2 all-available efficacy ;;Evaluable efficacy (7 days)  ;Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);  
BNT162b2 (30 μg);C4591001 1231 12315518;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 1231 12315600;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1232 12321033;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 1232 12321037;Dose 1 all-available efficacy Dose 2 all-available efficacy Evaluable efficacy (7 days) ;Dose 1 all-available efficacy ;Dose 2 all-available efficacy ;Evaluable efficacy (7 days) ;Did not receive at least 1 vaccination;  Did not receive 2 vaccinations;"  Randomized but did not meet all eligibility criteria; did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1)"
BNT162b2 (30 μg);C4591001 1232 12321101;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1232 12321175;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1232 12321219;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 1232 12321233;Dose 2 all-available efficacy Evaluable efficacy (7 days)  ;Dose 2 all-available efficacy ;;Evaluable efficacy (7 days)  ;Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);  
BNT162b2 (30 μg);C4591001 1232 12321250;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 1232 12321293;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1232 12321299;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1232 12321305;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 1232 12321354;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Had other important protocol deviations on or prior to 7 days after Dose 2;;
BNT162b2 (30 μg);C4591001 1232 12321361;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1232 12321373;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Had other important protocol deviations on or prior to 7 days after Dose 2;;
BNT162b2 (30 μg);C4591001 1232 12321382;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Had other important protocol deviations on or prior to 7 days after Dose 2;;
BNT162b2 (30 μg);C4591001 1232 12321385;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Had other important protocol deviations on or prior to 7 days after Dose 2;;
BNT162b2 (30 μg);C4591001 1232 12321394;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Had other important protocol deviations on or prior to 7 days after Dose 2;;
BNT162b2 (30 μg);C4591001 1232 12321395;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Had other important protocol deviations on or prior to 7 days after Dose 2;;
BNT162b2 (30 μg);C4591001 1232 12321396;Dose 2 all-available efficacy   Evaluable efficacy (7 days);Dose 2 all-available efficacy   ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;    Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1232 12321412;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1232 12321419;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1232 12321425;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1235 12351188;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1241 12411132;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 1241 12411144;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 1241 12411482;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1241 12411766;Dose 2 all-available efficacy Evaluable efficacy (7 days)  ;Dose 2 all-available efficacy ;;Evaluable efficacy (7 days)  ;Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);  
BNT162b2 (30 μg);C4591001 1241 12411993;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 1241 12412382;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 1246 12461025;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1247 12471054;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 1247 12471149;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1247 12471151;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1248 12481025;Dose 1 all-available efficacy Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 1 all-available efficacy ;Dose 2 all-available efficacy ;Evaluable efficacy (7 days);Did not receive at least 1 vaccination;  Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1)
BNT162b2 (30 μg);C4591001 1248 12481048;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1248 12481169;Evaluable efficacy (7 days)  ;;;Evaluable efficacy (7 days)  ;Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);  ;
BNT162b2 (30 μg);C4591001 1248 12481175;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1251 12511095;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1251 12511204;Dose 1 all-available efficacy Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 1 all-available efficacy ;Dose 2 all-available efficacy ;Evaluable efficacy (7 days);Did not receive at least 1 vaccination;  Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1)
BNT162b2 (30 μg);C4591001 1254 12541023;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1254 12541142;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1254 12541154;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1260 12601049;Dose 1 all-available efficacy Dose 2 all-available efficacy   Evaluable efficacy (7 days) ;Dose 1 all-available efficacy ;Dose 2 all-available efficacy   ;Evaluable efficacy (7 days) ;Did not receive at least 1 vaccination;  Did not receive 2 vaccinations;"    Randomized but did not meet all eligibility criteria; did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1)"
BNT162b2 (30 μg);C4591001 1260 12601126;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 1261 12611054;Evaluable efficacy (7 days)  ;;;Evaluable efficacy (7 days)  ;"Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1); had other important protocol deviations on or prior to 7 days after Dose 2";;
BNT162b2 (30 μg);C4591001 1265 12651164;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);"Randomized but did not meet all eligibility criteria; had other important protocol deviations on or prior to 7 days after Dose 2";;
BNT162b2 (30 μg);C4591001 4444 44441043;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 4444 44441134;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 4444 44441135;Dose 1 all-available efficacy Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 1 all-available efficacy ;Dose 2 all-available efficacy ;Evaluable efficacy (7 days);Did not receive at least 1 vaccination;  Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1)
BNT162b2 (30 μg);C4591001 4444 44441273;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 4444 44441569;Dose 2 all-available efficacy   Evaluable efficacy (7 days);Dose 2 all-available efficacy   ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;    Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 4444 44441572;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 4444 44441818;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 4444 44441951;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 4444 44442058;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 4444 44442062;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 4444 44442065;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 4444 44442070;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 4444 44442080;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 4444 44442084;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 4444 44442085;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 4444 44442087;Evaluable efficacy (7 days)  ;;;Evaluable efficacy (7 days)  ;Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);  ;
BNT162b2 (30 μg);C4591001 4444 44442088;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 4444 44442093;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 4444 44442113;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 4444 44442114;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 4444 44442131;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 4444 44442135;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 4444 44442157;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 4444 44442159;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 4444 44442174;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 4444 44442188;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 4444 44442190;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 4444 44442194;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 4444 44442197;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 4444 44442199;Evaluable efficacy (7 days)  ;;;Evaluable efficacy (7 days)  ;Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);  ;
BNT162b2 (30 μg);C4591001 4444 44442216;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 4444 44442217;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 4444 44442219;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 4444 44442226;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 4444 44442236;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 4444 44442241;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 4444 44442245;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 4444 44442250;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 4444 44442255;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 4444 44442262;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 4444 44442268;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 4444 44442269;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 4444 44442270;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 4444 44442277;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 4444 44442278;Evaluable efficacy (7 days)  ;;;Evaluable efficacy (7 days)  ;Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);  ;
BNT162b2 (30 μg);C4591001 4444 44442283;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 4444 44442287;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 4444 44442288;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 4444 44442298;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 4444 44442306;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 4444 44442313;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 4444 44442314;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 4444 44442319;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1003 10031120;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Had other important protocol deviations on or prior to 7 days after Dose 2;;
BNT162b2 (30 μg);C4591001 1005 10051214;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1005 10051293;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1005 10051403;Dose 2 all-available efficacy   Evaluable efficacy (7 days);Dose 2 all-available efficacy   ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;    Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1007 10071105;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Had other important protocol deviations on or prior to 7 days after Dose 2;;
BNT162b2 (30 μg);C4591001 1007 10071213;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 1011 10111028;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 1011 10111181;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1011 10111201;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 1012 10121139;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 1012 10121149;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1013 10131176;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 1013 10131186;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 1013 10131714;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1016 10161026;Evaluable efficacy (7 days)  ;;;Evaluable efficacy (7 days)  ;Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);  ;
BNT162b2 (30 μg);C4591001 1016 10161162;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 1019 10191201;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1019 10191299;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1019 10191308;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Unblinded prior to 7 days post Dose 2;  Unblinded prior to 7 days post Dose 2; 
BNT162b2 (30 μg);C4591001 1019 10191314;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 1021 10211221;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 1022 10221150;Dose 1 all-available efficacy Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 1 all-available efficacy ;Dose 2 all-available efficacy ;Evaluable efficacy (7 days);Did not receive at least 1 vaccination;  Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1)
BNT162b2 (30 μg);C4591001 1024 10241003;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Had other important protocol deviations on or prior to 7 days after Dose 2;;
BNT162b2 (30 μg);C4591001 1024 10241031;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Had other important protocol deviations on or prior to 7 days after Dose 2;;
BNT162b2 (30 μg);C4591001 1024 10241037;Evaluable efficacy (7 days)  ;;;Evaluable efficacy (7 days)  ;Had other important protocol deviations on or prior to 7 days after Dose 2;  ;
BNT162b2 (30 μg);C4591001 1024 10241041;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Had other important protocol deviations on or prior to 7 days after Dose 2;;
BNT162b2 (30 μg);C4591001 1024 10241049;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Had other important protocol deviations on or prior to 7 days after Dose 2;;
BNT162b2 (30 μg);C4591001 1024 10241057;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Had other important protocol deviations on or prior to 7 days after Dose 2;;
BNT162b2 (30 μg);C4591001 1024 10241059;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Had other important protocol deviations on or prior to 7 days after Dose 2;;
BNT162b2 (30 μg);C4591001 1024 10241065;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Had other important protocol deviations on or prior to 7 days after Dose 2;;
BNT162b2 (30 μg);C4591001 1024 10241068;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Had other important protocol deviations on or prior to 7 days after Dose 2;;
BNT162b2 (30 μg);C4591001 1024 10241077;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1024 10241081;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Had other important protocol deviations on or prior to 7 days after Dose 2;;
BNT162b2 (30 μg);C4591001 1024 10241083;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Had other important protocol deviations on or prior to 7 days after Dose 2;;
BNT162b2 (30 μg);C4591001 1024 10241087;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Had other important protocol deviations on or prior to 7 days after Dose 2;;
BNT162b2 (30 μg);C4591001 1024 10241096;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Had other important protocol deviations on or prior to 7 days after Dose 2;;
BNT162b2 (30 μg);C4591001 1024 10241097;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Had other important protocol deviations on or prior to 7 days after Dose 2;;
BNT162b2 (30 μg);C4591001 1027 10271206;Dose 2 all-available efficacy Evaluable efficacy (7 days)  ;Dose 2 all-available efficacy ;;Evaluable efficacy (7 days)  ;Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);  
BNT162b2 (30 μg);C4591001 1037 10371057;Dose 1 all-available efficacy Dose 2 all-available efficacy Evaluable efficacy (7 days) ;Dose 1 all-available efficacy ;Dose 2 all-available efficacy ;Evaluable efficacy (7 days) ;Did not receive at least 1 vaccination;  Did not receive 2 vaccinations;"  Randomized but did not meet all eligibility criteria; did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1)"
BNT162b2 (30 μg);C4591001 1037 10371275;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 1037 10371356;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Had other important protocol deviations on or prior to 7 days after Dose 2;;
BNT162b2 (30 μg);C4591001 1039 10391019;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1044 10441002;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Had other important protocol deviations on or prior to 7 days after Dose 2;;
BNT162b2 (30 μg);C4591001 1044 10441004;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Had other important protocol deviations on or prior to 7 days after Dose 2;;
BNT162b2 (30 μg);C4591001 1044 10441007;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Had other important protocol deviations on or prior to 7 days after Dose 2;;
BNT162b2 (30 μg);C4591001 1044 10441010;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Had other important protocol deviations on or prior to 7 days after Dose 2;;
BNT162b2 (30 μg);C4591001 1044 10441016;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Had other important protocol deviations on or prior to 7 days after Dose 2;;
BNT162b2 (30 μg);C4591001 1044 10441018;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Had other important protocol deviations on or prior to 7 days after Dose 2;;
BNT162b2 (30 μg);C4591001 1044 10441032;Evaluable efficacy (7 days)  ;;;Evaluable efficacy (7 days)  ;Had other important protocol deviations on or prior to 7 days after Dose 2;  ;
BNT162b2 (30 μg);C4591001 1044 10441036;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Had other important protocol deviations on or prior to 7 days after Dose 2;;
BNT162b2 (30 μg);C4591001 1044 10441041;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Had other important protocol deviations on or prior to 7 days after Dose 2;;
BNT162b2 (30 μg);C4591001 1044 10441047;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Had other important protocol deviations on or prior to 7 days after Dose 2;;
BNT162b2 (30 μg);C4591001 1044 10441049;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Had other important protocol deviations on or prior to 7 days after Dose 2;;
BNT162b2 (30 μg);C4591001 1044 10441055;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Had other important protocol deviations on or prior to 7 days after Dose 2;;
BNT162b2 (30 μg);C4591001 1044 10441062;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Had other important protocol deviations on or prior to 7 days after Dose 2;;
BNT162b2 (30 μg);C4591001 1044 10441067;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Had other important protocol deviations on or prior to 7 days after Dose 2;;
BNT162b2 (30 μg);C4591001 1044 10441073;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Had other important protocol deviations on or prior to 7 days after Dose 2;;
BNT162b2 (30 μg);C4591001 1044 10441075;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Had other important protocol deviations on or prior to 7 days after Dose 2;;
BNT162b2 (30 μg);C4591001 1044 10441080;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Had other important protocol deviations on or prior to 7 days after Dose 2;;
BNT162b2 (30 μg);C4591001 1044 10441083;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Had other important protocol deviations on or prior to 7 days after Dose 2;;
BNT162b2 (30 μg);C4591001 1044 10441085;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Had other important protocol deviations on or prior to 7 days after Dose 2;;
BNT162b2 (30 μg);C4591001 1044 10441090;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Had other important protocol deviations on or prior to 7 days after Dose 2;;
BNT162b2 (30 μg);C4591001 1044 10441092;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Had other important protocol deviations on or prior to 7 days after Dose 2;;
BNT162b2 (30 μg);C4591001 1044 10441093;Evaluable efficacy (7 days)  ;;;Evaluable efficacy (7 days)  ;Had other important protocol deviations on or prior to 7 days after Dose 2;  ;
BNT162b2 (30 μg);C4591001 1044 10441094;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Had other important protocol deviations on or prior to 7 days after Dose 2;;
BNT162b2 (30 μg);C4591001 1044 10441113;Dose 1 all-available efficacy Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 1 all-available efficacy ;Dose 2 all-available efficacy ;Evaluable efficacy (7 days);Did not receive at least 1 vaccination;  Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1)
BNT162b2 (30 μg);C4591001 1046 10461084;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 1046 10461245;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 1047 10471122;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);"Randomized but did not meet all eligibility criteria; had other important protocol deviations on or prior to 7 days after Dose 2";;
BNT162b2 (30 μg);C4591001 1047 10471228;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);"Randomized but did not meet all eligibility criteria; had other important protocol deviations on or prior to 7 days after Dose 2";;
BNT162b2 (30 μg);C4591001 1047 10471300;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 1052 10521062;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1052 10521142;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 1054 10541071;Dose 1 all-available efficacy Dose 2 all-available efficacy Evaluable efficacy (7 days)  ;Dose 1 all-available efficacy ;Dose 2 all-available efficacy ;Evaluable efficacy (7 days)  ;Did not receive at least 1 vaccination;  Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1)
BNT162b2 (30 μg);C4591001 1054 10541175;Dose 1 all-available efficacy Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 1 all-available efficacy ;Dose 2 all-available efficacy ;Evaluable efficacy (7 days);Did not receive at least 1 vaccination;  Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1)
BNT162b2 (30 μg);C4591001 1056 10561034;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 1056 10561078;Dose 1 all-available efficacy Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 1 all-available efficacy ;Dose 2 all-available efficacy ;Evaluable efficacy (7 days);Did not receive at least 1 vaccination;  Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1)
BNT162b2 (30 μg);C4591001 1056 10561095;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 1056 10561120;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1056 10561123;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1056 10561229;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 1056 10561298;Dose 2 all-available efficacy Evaluable efficacy (7 days)  ;Dose 2 all-available efficacy ;;Evaluable efficacy (7 days)  ;Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);  
BNT162b2 (30 μg);C4591001 1056 10561301;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 1056 10561303;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 1056 10561306;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 1056 10561353;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 1056 10561399;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 1056 10561404;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 1056 10561409;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 1056 10561625;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1066 10661128;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1068 10681004;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Had other important protocol deviations on or prior to 7 days after Dose 2;;
BNT162b2 (30 μg);C4591001 1068 10681005;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Had other important protocol deviations on or prior to 7 days after Dose 2;;
BNT162b2 (30 μg);C4591001 1068 10681008;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Had other important protocol deviations on or prior to 7 days after Dose 2;;
BNT162b2 (30 μg);C4591001 1068 10681009;Evaluable efficacy (7 days)  ;;;Evaluable efficacy (7 days)  ;Had other important protocol deviations on or prior to 7 days after Dose 2;  ;
BNT162b2 (30 μg);C4591001 1068 10681019;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Had other important protocol deviations on or prior to 7 days after Dose 2;;
BNT162b2 (30 μg);C4591001 1068 10681023;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Had other important protocol deviations on or prior to 7 days after Dose 2;;
BNT162b2 (30 μg);C4591001 1068 10681029;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Had other important protocol deviations on or prior to 7 days after Dose 2;;
BNT162b2 (30 μg);C4591001 1068 10681030;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Had other important protocol deviations on or prior to 7 days after Dose 2;;
BNT162b2 (30 μg);C4591001 1068 10681039;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Had other important protocol deviations on or prior to 7 days after Dose 2;;
BNT162b2 (30 μg);C4591001 1068 10681041;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Had other important protocol deviations on or prior to 7 days after Dose 2;;
BNT162b2 (30 μg);C4591001 1068 10681044;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Had other important protocol deviations on or prior to 7 days after Dose 2;;
BNT162b2 (30 μg);C4591001 1068 10681050;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Had other important protocol deviations on or prior to 7 days after Dose 2;;
BNT162b2 (30 μg);C4591001 1068 10681056;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Had other important protocol deviations on or prior to 7 days after Dose 2;;
BNT162b2 (30 μg);C4591001 1068 10681057;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Had other important protocol deviations on or prior to 7 days after Dose 2;;
BNT162b2 (30 μg);C4591001 1068 10681059;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Had other important protocol deviations on or prior to 7 days after Dose 2;;
BNT162b2 (30 μg);C4591001 1068 10681062;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Had other important protocol deviations on or prior to 7 days after Dose 2;;
BNT162b2 (30 μg);C4591001 1068 10681068;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Had other important protocol deviations on or prior to 7 days after Dose 2;;
BNT162b2 (30 μg);C4591001 1068 10681078;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Had other important protocol deviations on or prior to 7 days after Dose 2;;
BNT162b2 (30 μg);C4591001 1068 10681079;Evaluable efficacy (7 days)  ;;;Evaluable efficacy (7 days)  ;Had other important protocol deviations on or prior to 7 days after Dose 2;  ;
BNT162b2 (30 μg);C4591001 1068 10681084;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Had other important protocol deviations on or prior to 7 days after Dose 2;;
BNT162b2 (30 μg);C4591001 1071 10711023;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1071 10711169;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1071 10711178;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 1072 10721065;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1079 10791234;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 1079 10791264;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 1079 10791271;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 1079 10791283;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 1080 10801064;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1080 10801217;Evaluable efficacy (7 days)  ;;;Evaluable efficacy (7 days)  ;Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);  ;
BNT162b2 (30 μg);C4591001 1081 10811053;Evaluable efficacy (7 days)  ;;;Evaluable efficacy (7 days)  ;"Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1); had other important protocol deviations on or prior to 7 days after Dose 2";;
BNT162b2 (30 μg);C4591001 1081 10811061;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 1081 10811139;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 1081 10811150;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 1082 10821062;Dose 1 all-available efficacy Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 1 all-available efficacy ;Dose 2 all-available efficacy ;Evaluable efficacy (7 days);Did not receive at least 1 vaccination;  Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1)
BNT162b2 (30 μg);C4591001 1082 10821126;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1083 10831173;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1084 10841403;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Had other important protocol deviations on or prior to 7 days after Dose 2;;
BNT162b2 (30 μg);C4591001 1084 10841446;Dose 1 all-available efficacy Dose 2 all-available efficacy   Evaluable efficacy (7 days);Dose 1 all-available efficacy ;Dose 2 all-available efficacy   ;Evaluable efficacy (7 days);Did not receive at least 1 vaccination;  Did not receive 2 vaccinations;    Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1)
BNT162b2 (30 μg);C4591001 1087 10871080;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1087 10871121;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1087 10871224;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 1087 10871418;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 1087 10871434;Dose 1 all-available efficacy Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 1 all-available efficacy ;Dose 2 all-available efficacy ;Evaluable efficacy (7 days);Did not receive at least 1 vaccination;  Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1)
BNT162b2 (30 μg);C4591001 1087 10871512;Dose 1 all-available efficacy Dose 2 all-available efficacy Evaluable efficacy (7 days) ;Dose 1 all-available efficacy ;Dose 2 all-available efficacy ;Evaluable efficacy (7 days) ;Did not receive at least 1 vaccination;  Did not receive 2 vaccinations;"  Randomized but did not meet all eligibility criteria; did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1)"
BNT162b2 (30 μg);C4591001 1088 10881122;Evaluable efficacy (7 days)  ;;;Evaluable efficacy (7 days)  ;Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);  ;
BNT162b2 (30 μg);C4591001 1088 10881139;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 1089 10891093;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 1090 10901237;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 1091 10911001;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Had other important protocol deviations on or prior to 7 days after Dose 2;;
BNT162b2 (30 μg);C4591001 1091 10911004;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Had other important protocol deviations on or prior to 7 days after Dose 2;;
BNT162b2 (30 μg);C4591001 1091 10911010;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Had other important protocol deviations on or prior to 7 days after Dose 2;;
BNT162b2 (30 μg);C4591001 1091 10911012;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Had other important protocol deviations on or prior to 7 days after Dose 2;;
BNT162b2 (30 μg);C4591001 1091 10911092;Dose 1 all-available efficacy Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 1 all-available efficacy ;Dose 2 all-available efficacy ;Evaluable efficacy (7 days);Did not receive at least 1 vaccination;  Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1)
BNT162b2 (30 μg);C4591001 1091 10911159;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 1091 10911195;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 1092 10921015;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 1092 10921180;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 1092 10921268;Dose 2 all-available efficacy   Evaluable efficacy (7 days);Dose 2 all-available efficacy   ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;    Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1093 10931005;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 1094 10941046;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 1094 10941071;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 1094 10941159;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 1095 10951102;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1097 10971003;Dose 1 all-available efficacy Dose 2 all-available efficacy Evaluable efficacy (7 days) ;Dose 1 all-available efficacy ;Dose 2 all-available efficacy ;Evaluable efficacy (7 days) ;Did not receive at least 1 vaccination;  Did not receive 2 vaccinations;"  Randomized but did not meet all eligibility criteria; did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1)"
BNT162b2 (30 μg);C4591001 1097 10971023;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Had other important protocol deviations on or prior to 7 days after Dose 2;;
BNT162b2 (30 μg);C4591001 1097 10971024;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 1097 10971097;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 1097 10971107;Evaluable efficacy (7 days)  ;;;Evaluable efficacy (7 days)  ;"Randomized but did not meet all eligibility criteria; had other important protocol deviations on or prior to 7 days after Dose 2";  ;
BNT162b2 (30 μg);C4591001 1098 10981030;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1098 10981092;Dose 1 all-available efficacy Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 1 all-available efficacy ;Dose 2 all-available efficacy ;Evaluable efficacy (7 days);Did not receive at least 1 vaccination;  Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1)
BNT162b2 (30 μg);C4591001 1098 10981109;Dose 1 all-available efficacy Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 1 all-available efficacy ;Dose 2 all-available efficacy ;Evaluable efficacy (7 days);Did not receive at least 1 vaccination;  Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1)
BNT162b2 (30 μg);C4591001 1098 10981162;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);"Randomized but did not meet all eligibility criteria; had other important protocol deviations on or prior to 7 days after Dose 2";;
BNT162b2 (30 μg);C4591001 1101 11011027;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 1109 11091259;Dose 1 all-available efficacy Dose 2 all-available efficacy Evaluable efficacy (7 days) ;Dose 1 all-available efficacy ;Dose 2 all-available efficacy ;Evaluable efficacy (7 days) ;Did not receive at least 1 vaccination;  Did not receive 2 vaccinations;"  Randomized but did not meet all eligibility criteria; did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1)"
BNT162b2 (30 μg);C4591001 1109 11091345;Evaluable efficacy (7 days)  ;;;Evaluable efficacy (7 days)  ;Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);  ;
BNT162b2 (30 μg);C4591001 1109 11091374;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 1109 11091475;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1109 11091503;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1110 11101309;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 1112 11121118;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1112 11121134;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1112 11121255;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1116 11161117;Dose 1 all-available efficacy Dose 2 all-available efficacy Evaluable efficacy (7 days)  ;Dose 1 all-available efficacy ;Dose 2 all-available efficacy ;Evaluable efficacy (7 days)  ;Did not receive at least 1 vaccination;  Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1)
BNT162b2 (30 μg);C4591001 1116 11161227;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 1117 11171047;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 1118 11181072;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1120 11201350;Dose 2 all-available efficacy Evaluable efficacy (7 days) ;Dose 2 all-available efficacy ;;Evaluable efficacy (7 days) ;Unblinded prior to 7 days post Dose 2;"  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1); unblinded prior to 7 days post Dose 2";
BNT162b2 (30 μg);C4591001 1121 11211071;Evaluable efficacy (7 days)  ;;;Evaluable efficacy (7 days)  ;"Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1); had other important protocol deviations on or prior to 7 days after Dose 2";;
BNT162b2 (30 μg);C4591001 1122 11221034;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Had other important protocol deviations on or prior to 7 days after Dose 2;;
BNT162b2 (30 μg);C4591001 1125 11251222;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1127 11271002;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 1127 11271034;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 1128 11281313;Evaluable efficacy (7 days)  ;;;Evaluable efficacy (7 days)  ;Had other important protocol deviations on or prior to 7 days after Dose 2;  ;
BNT162b2 (30 μg);C4591001 1128 11281325;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 1129 11291091;Evaluable efficacy (7 days)  ;;;Evaluable efficacy (7 days)  ;"Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1); had other important protocol deviations on or prior to 7 days after Dose 2";;
BNT162b2 (30 μg);C4591001 1129 11291115;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Had other important protocol deviations on or prior to 7 days after Dose 2;;
BNT162b2 (30 μg);C4591001 1129 11291117;Dose 1 all-available efficacy Dose 2 all-available efficacy Evaluable efficacy (7 days) ;Dose 1 all-available efficacy ;Dose 2 all-available efficacy ;Evaluable efficacy (7 days) ;Did not receive at least 1 vaccination;  Did not receive 2 vaccinations;"  Randomized but did not meet all eligibility criteria; did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1)"
BNT162b2 (30 μg);C4591001 1129 11291149;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 1129 11291166;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Had other important protocol deviations on or prior to 7 days after Dose 2;;
BNT162b2 (30 μg);C4591001 1130 11301039;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Had other important protocol deviations on or prior to 7 days after Dose 2;;
BNT162b2 (30 μg);C4591001 1133 11331197;Dose 1 all-available efficacy Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 1 all-available efficacy ;Dose 2 all-available efficacy ;Evaluable efficacy (7 days);Did not receive at least 1 vaccination;  Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1)
BNT162b2 (30 μg);C4591001 1133 11331472;Dose 2 all-available efficacy   Evaluable efficacy (7 days);Dose 2 all-available efficacy   ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;    Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1134 11341052;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 1134 11341099;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 1134 11341101;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 1134 11341353;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 1135 11351131;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 1136 11361096;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 1136 11361107;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 1141 11411066;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Had other important protocol deviations on or prior to 7 days after Dose 2;;
BNT162b2 (30 μg);C4591001 1142 11421111;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1142 11421304;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 1149 11491126;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1149 11491224;Dose 2 all-available efficacy   Evaluable efficacy (7 days);Dose 2 all-available efficacy   ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;    Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1149 11491239;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1149 11491296;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 1152 11521359;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1152 11521476;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1152 11521497;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1157 11571144;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 1161 11611012;Dose 1 all-available efficacy Dose 2 all-available efficacy Evaluable efficacy (7 days)     ;Dose 1 all-available efficacy ;Dose 2 all-available efficacy ;Evaluable efficacy (7 days)     ;Data considered potentially unreliable due to lack of PI oversight identified as significant quality event; Data considered potentially unreliable due to lack of PI oversight identified as significant quality event;" Data considered potentially unreliable due to lack of PI oversight identified as significant quality event; did not receive all vaccinations as randomized or did not receive Dose 2 within the   predefined window (19-42 days after Dose 1); had other important protocol deviations on or prior to 7 days after Dose 2"
BNT162b2 (30 μg);C4591001 1161 11611013;Dose 1 all-available efficacy Dose 2 all-available efficacy Evaluable efficacy (7 days)   ;Dose 1 all-available efficacy ;Dose 2 all-available efficacy ;Evaluable efficacy (7 days)   ;Data considered potentially unreliable due to lack of PI oversight identified as significant quality event; Data considered potentially unreliable due to lack of PI oversight identified as significant quality event;" Data considered potentially unreliable due to lack of PI oversight identified as significant quality event; did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1); had other important protocol deviations on or prior to 7 days after Dose 2"
BNT162b2 (30 μg);C4591001 1161 11611022;Dose 1 all-available efficacy Dose 2 all-available efficacy Evaluable efficacy (7 days)   ;Dose 1 all-available efficacy ;Dose 2 all-available efficacy ;Evaluable efficacy (7 days)   ;Data considered potentially unreliable due to lack of PI oversight identified as significant quality event; Data considered potentially unreliable due to lack of PI oversight identified as significant quality event;" Data considered potentially unreliable due to lack of PI oversight identified as significant quality event; did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1); had other important protocol deviations on or prior to 7 days after Dose 2"
BNT162b2 (30 μg);C4591001 1161 11611030;Dose 1 all-available efficacy Dose 2 all-available efficacy Evaluable efficacy (7 days)   ;Dose 1 all-available efficacy ;Dose 2 all-available efficacy ;Evaluable efficacy (7 days)   ;Data considered potentially unreliable due to lack of PI oversight identified as significant quality event; Data considered potentially unreliable due to lack of PI oversight identified as significant quality event;" Data considered potentially unreliable due to lack of PI oversight identified as significant quality event; did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1); had other important protocol deviations on or prior to 7 days after Dose 2"
BNT162b2 (30 μg);C4591001 1161 11611035;Dose 1 all-available efficacy   Dose 2 all-available efficacy Evaluable efficacy (7 days)   ;Dose 1 all-available efficacy   ;Dose 2 all-available efficacy ;Evaluable efficacy (7 days)   ;Data considered potentially unreliable due to lack of PI oversight identified as significant quality event;   Data considered potentially unreliable due to lack of PI oversight identified as significant quality event;" Data considered potentially unreliable due to lack of PI oversight identified as significant quality event; did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1); had other important protocol deviations on or prior to 7 days after Dose 2"
BNT162b2 (30 μg);C4591001 1161 11611036;Dose 1 all-available efficacy Dose 2 all-available efficacy Evaluable efficacy (7 days)   ;Dose 1 all-available efficacy ;Dose 2 all-available efficacy ;Evaluable efficacy (7 days)   ;Data considered potentially unreliable due to lack of PI oversight identified as significant quality event; Data considered potentially unreliable due to lack of PI oversight identified as significant quality event;" Data considered potentially unreliable due to lack of PI oversight identified as significant quality event; did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1); had other important protocol deviations on or prior to 7 days after Dose 2"
BNT162b2 (30 μg);C4591001 1161 11611037;Dose 1 all-available efficacy Dose 2 all-available efficacy Evaluable efficacy (7 days)   ;Dose 1 all-available efficacy ;Dose 2 all-available efficacy ;Evaluable efficacy (7 days)   ;Data considered potentially unreliable due to lack of PI oversight identified as significant quality event; Data considered potentially unreliable due to lack of PI oversight identified as significant quality event;" Data considered potentially unreliable due to lack of PI oversight identified as significant quality event; did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1); had other important protocol deviations on or prior to 7 days after Dose 2"
BNT162b2 (30 μg);C4591001 1161 11611042;Dose 1 all-available efficacy Dose 2 all-available efficacy Evaluable efficacy (7 days)     ;Dose 1 all-available efficacy ;Dose 2 all-available efficacy ;Evaluable efficacy (7 days)     ;Data considered potentially unreliable due to lack of PI oversight identified as significant quality event; Data considered potentially unreliable due to lack of PI oversight identified as significant quality event;" Data considered potentially unreliable due to lack of PI oversight identified as significant quality event; did not receive all   vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1); had other important protocol deviations on or prior to 7 days after Dose 2"
BNT162b2 (30 μg);C4591001 1162 11621006;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 1162 11621007;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 1162 11621212;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 1162 11621327;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1162 11621349;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1162 11621407;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1162 11621433;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 1163 11631005;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1163 11631011;Evaluable efficacy (7 days)  ;;;Evaluable efficacy (7 days)  ;Had other important protocol deviations on or prior to 7 days after Dose 2;  ;
BNT162b2 (30 μg);C4591001 1163 11631013;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Had other important protocol deviations on or prior to 7 days after Dose 2;;
BNT162b2 (30 μg);C4591001 1163 11631126;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Had other important protocol deviations on or prior to 7 days after Dose 2;;
BNT162b2 (30 μg);C4591001 1163 11631131;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Had other important protocol deviations on or prior to 7 days after Dose 2;;
BNT162b2 (30 μg);C4591001 1163 11631132;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Had other important protocol deviations on or prior to 7 days after Dose 2;;
BNT162b2 (30 μg);C4591001 1163 11631133;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Had other important protocol deviations on or prior to 7 days after Dose 2;;
BNT162b2 (30 μg);C4591001 1163 11631144;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Had other important protocol deviations on or prior to 7 days after Dose 2;;
BNT162b2 (30 μg);C4591001 1163 11631149;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Had other important protocol deviations on or prior to 7 days after Dose 2;;
BNT162b2 (30 μg);C4591001 1167 11671122;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 1167 11671123;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 1168 11681015;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1169 11691070;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 1170 11701067;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 1170 11701354;Dose 2 all-available efficacy Evaluable efficacy (7 days)  ;Dose 2 all-available efficacy ;;Evaluable efficacy (7 days)  ;Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);  
BNT162b2 (30 μg);C4591001 1171 11711160;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 1171 11711217;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 1171 11711218;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 1171 11711227;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 1171 11711233;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 1171 11711243;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 1177 11771232;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 1185 11851006;Dose 1 all-available efficacy Dose 2 all-available efficacy Evaluable efficacy (7 days) ;Dose 1 all-available efficacy ;Dose 2 all-available efficacy ;Evaluable efficacy (7 days) ;Did not receive at least 1 vaccination;  Did not receive 2 vaccinations;"  Randomized but did not meet all eligibility criteria; did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1)"
BNT162b2 (30 μg);C4591001 1197 11971036;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 1197 11971037;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 1197 11971047;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 1207 12071030;Dose 2 all-available efficacy   Evaluable efficacy (7 days);Dose 2 all-available efficacy   ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;    Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1214 12141046;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 1218 12181056;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Unblinded prior to 7 days post Dose 2;  Unblinded prior to 7 days post Dose 2; 
BNT162b2 (30 μg);C4591001 1219 12191036;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Unblinded prior to 7 days post Dose 2;  Unblinded prior to 7 days post Dose 2; 
BNT162b2 (30 μg);C4591001 1220 12201060;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1221 12211051;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Unblinded prior to 7 days post Dose 2;  Unblinded prior to 7 days post Dose 2; 
BNT162b2 (30 μg);C4591001 1221 12211052;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Unblinded prior to 7 days post Dose 2;  Unblinded prior to 7 days post Dose 2; 
BNT162b2 (30 μg);C4591001 1221 12211058;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Unblinded prior to 7 days post Dose 2;  Unblinded prior to 7 days post Dose 2; 
BNT162b2 (30 μg);C4591001 1221 12211061;Dose 2 all-available efficacy   Evaluable efficacy (7 days);Dose 2 all-available efficacy   ;;Evaluable efficacy (7 days);Unblinded prior to 7 days post Dose 2;    Unblinded prior to 7 days post Dose 2; 
BNT162b2 (30 μg);C4591001 1223 12231215;Dose 1 all-available efficacy Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 1 all-available efficacy ;Dose 2 all-available efficacy ;Evaluable efficacy (7 days);Did not receive at least 1 vaccination;  Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1)
BNT162b2 (30 μg);C4591001 1223 12231250;Dose 1 all-available efficacy Dose 2 all-available efficacy Evaluable efficacy (7 days) ;Dose 1 all-available efficacy ;Dose 2 all-available efficacy ;Evaluable efficacy (7 days) ;Did not receive at least 1 vaccination;  Did not receive 2 vaccinations;"  Randomized but did not meet all eligibility criteria; did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1)"
BNT162b2 (30 μg);C4591001 1224 12241012;Dose 2 all-available efficacy Evaluable efficacy (7 days) ;Dose 2 all-available efficacy ;;Evaluable efficacy (7 days) ;Unblinded prior to 7 days post Dose 2;"  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1); unblinded prior to 7 days post Dose 2";
BNT162b2 (30 μg);C4591001 1229 12291041;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1231 12311709;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1231 12311815;Dose 2 all-available efficacy   Evaluable efficacy (7 days);Dose 2 all-available efficacy   ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;    Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1231 12312098;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 1231 12312222;Dose 1 all-available efficacy Dose 2 all-available efficacy Evaluable efficacy (7 days) ;Dose 1 all-available efficacy ;Dose 2 all-available efficacy ;Evaluable efficacy (7 days) ;Did not receive at least 1 vaccination;  Did not receive 2 vaccinations;"  Randomized but did not meet all eligibility criteria; did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1)"
BNT162b2 (30 μg);C4591001 1231 12312496;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 1231 12313003;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1231 12313359;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 1231 12313391;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 1231 12313446;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Unblinded prior to 7 days post Dose 2;"  Unblinded prior to 7 days post Dose 2; had other important protocol deviations on or prior to 7 days after Dose 2";
BNT162b2 (30 μg);C4591001 1231 12313461;Dose 2 all-available efficacy Evaluable efficacy (7 days)  ;Dose 2 all-available efficacy ;;Evaluable efficacy (7 days)  ;Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);  
BNT162b2 (30 μg);C4591001 1231 12313468;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1231 12313478;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1231 12313480;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1231 12313496;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Unblinded prior to 7 days post Dose 2;"  Unblinded prior to 7 days post Dose 2; had other important protocol deviations on or prior to 7 days after Dose 2";
BNT162b2 (30 μg);C4591001 1231 12313503;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Unblinded prior to 7 days post Dose 2;"  Unblinded prior to 7 days post Dose 2; had other important protocol deviations on or prior to 7 days after Dose 2";
BNT162b2 (30 μg);C4591001 1231 12313511;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Unblinded prior to 7 days post Dose 2;"  Unblinded prior to 7 days post Dose 2; had other important protocol deviations on or prior to 7 days after Dose 2";
BNT162b2 (30 μg);C4591001 1231 12313524;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Unblinded prior to 7 days post Dose 2;"  Unblinded prior to 7 days post Dose 2; had other important protocol deviations on or prior to 7 days after Dose 2";
BNT162b2 (30 μg);C4591001 1231 12313530;Dose 2 all-available efficacy   Evaluable efficacy (7 days);Dose 2 all-available efficacy   ;;Evaluable efficacy (7 days);Unblinded prior to 7 days post Dose 2;"    Unblinded prior to 7 days post Dose 2; had other important protocol deviations on or prior to 7 days after Dose 2";
BNT162b2 (30 μg);C4591001 1231 12313536;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Unblinded prior to 7 days post Dose 2;"  Unblinded prior to 7 days post Dose 2; had other important protocol deviations on or prior to 7 days after Dose 2";
BNT162b2 (30 μg);C4591001 1231 12313538;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1231 12313549;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Unblinded prior to 7 days post Dose 2;"  Unblinded prior to 7 days post Dose 2; had other important protocol deviations on or prior to 7 days after Dose 2";
BNT162b2 (30 μg);C4591001 1231 12313562;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Unblinded prior to 7 days post Dose 2;"  Unblinded prior to 7 days post Dose 2; had other important protocol deviations on or prior to 7 days after Dose 2";
BNT162b2 (30 μg);C4591001 1231 12313651;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1231 12314060;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1231 12314216;Dose 2 all-available efficacy Evaluable efficacy (7 days)  ;Dose 2 all-available efficacy ;;Evaluable efficacy (7 days)  ;Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);  
BNT162b2 (30 μg);C4591001 1231 12314301;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1231 12314488;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 1231 12315018;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 1231 12315246;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1232 12321105;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 1232 12321144;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 1232 12321326;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 1232 12321367;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1232 12321383;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Had other important protocol deviations on or prior to 7 days after Dose 2;;
BNT162b2 (30 μg);C4591001 1232 12321389;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Had other important protocol deviations on or prior to 7 days after Dose 2;;
BNT162b2 (30 μg);C4591001 1232 12321390;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Had other important protocol deviations on or prior to 7 days after Dose 2;;
BNT162b2 (30 μg);C4591001 1232 12321398;Evaluable efficacy (7 days)  ;;;Evaluable efficacy (7 days)  ;Had other important protocol deviations on or prior to 7 days after Dose 2;  ;
BNT162b2 (30 μg);C4591001 1232 12321432;Dose 1 all-available efficacy Dose 2 all-available efficacy Evaluable efficacy (7 days) ;Dose 1 all-available efficacy ;Dose 2 all-available efficacy ;Evaluable efficacy (7 days) ;Did not receive at least 1 vaccination;  Did not receive 2 vaccinations;"  Randomized but did not meet all eligibility criteria; did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1)"
BNT162b2 (30 μg);C4591001 1248 12481026;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1248 12481044;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 1248 12481047;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 1248 12481182;Dose 1 all-available efficacy Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 1 all-available efficacy ;Dose 2 all-available efficacy ;Evaluable efficacy (7 days);Did not receive at least 1 vaccination;  Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1)
BNT162b2 (30 μg);C4591001 1248 12481214;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1251 12511050;Dose 2 all-available efficacy Evaluable efficacy (7 days)   ;Dose 2 all-available efficacy ;;Evaluable efficacy (7 days)   ;Did not receive 2 vaccinations;"  Randomized but did not meet all eligibility criteria; did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1)";  
BNT162b2 (30 μg);C4591001 1251 12511087;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 1251 12511236;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 1252 12521003;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 1254 12541200;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 1260 12601095;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 4444 44441495;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 4444 44441792;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
BNT162b2 (30 μg);C4591001 4444 44442012;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 4444 44442076;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 4444 44442078;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 4444 44442092;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 4444 44442098;Evaluable efficacy (7 days)  ;;;Evaluable efficacy (7 days)  ;Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);  ;
BNT162b2 (30 μg);C4591001 4444 44442110;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 4444 44442112;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 4444 44442130;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 4444 44442176;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 4444 44442183;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 4444 44442187;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 4444 44442204;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 4444 44442208;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 4444 44442239;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 4444 44442266;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 4444 44442271;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 4444 44442295;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
BNT162b2 (30 μg);C4591001 4444 44442316;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 1006 10061219;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 1007 10071415;Evaluable efficacy (7 days)  ;;;Evaluable efficacy (7 days)  ;Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);  ;
Placebo;C4591001 1007 10071593;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1008 10081871;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1008 10081884;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1009 10091229;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1009 10091320;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Had other important protocol deviations on or prior to 7 days after Dose 2;;
Placebo;C4591001 1009 10091338;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1009 10091363;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1009 10091366;Dose 2 all-available efficacy Evaluable efficacy (7 days)  ;Dose 2 all-available efficacy ;;Evaluable efficacy (7 days)  ;Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);  
Placebo;C4591001 1016 10161316;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1016 10161379;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1044 10441360;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 1077 10771293;Dose 1 all-available efficacy Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 1 all-available efficacy ;Dose 2 all-available efficacy ;Evaluable efficacy (7 days);Did not receive at least 1 vaccination;  Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1)
Placebo;C4591001 1123 11231501;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 1126 11261254;Evaluable efficacy (7 days)  ;;;Evaluable efficacy (7 days)  ;"Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1); had other important protocol deviations on or prior to 7 days after Dose 2";;
Placebo;C4591001 1126 11261287;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1131 11311292;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 1147 11471280;Dose 2 all-available efficacy   Evaluable efficacy (7 days);Dose 2 all-available efficacy   ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;    Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1270 12701237;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1003 10031140;Dose 1 all-available efficacy Dose 2 all-available efficacy Evaluable efficacy (7 days) ;Dose 1 all-available efficacy ;Dose 2 all-available efficacy ;Evaluable efficacy (7 days) ;Did not receive at least 1 vaccination;  Did not receive 2 vaccinations;"  Randomized but did not meet all eligibility criteria; did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1)"
Placebo;C4591001 1005 10051308;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1005 10051341;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1006 10061070;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 1006 10061099;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);"Randomized but did not meet all eligibility criteria; had other important protocol deviations on or prior to 7 days after Dose 2";;
Placebo;C4591001 1006 10061215;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 1006 10061246;Evaluable efficacy (7 days)  ;;;Evaluable efficacy (7 days)  ;"Randomized but did not meet all eligibility criteria; had other important protocol deviations on or prior to 7 days after Dose 2";  ;
Placebo;C4591001 1007 10071095;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 1007 10071407;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1008 10081682;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 1008 10081721;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1009 10091211;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1009 10091257;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1011 10111070;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 1011 10111175;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 1013 10131017;Dose 1 all-available efficacy Dose 2 all-available efficacy Evaluable efficacy (7 days)  ;Dose 1 all-available efficacy ;Dose 2 all-available efficacy ;Evaluable efficacy (7 days)  ;Did not receive at least 1 vaccination;  Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1)
Placebo;C4591001 1013 10131034;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 1013 10131040;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 1013 10131216;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1013 10131426;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1013 10131740;Dose 1 all-available efficacy Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 1 all-available efficacy ;Dose 2 all-available efficacy ;Evaluable efficacy (7 days);Did not receive at least 1 vaccination;  Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1)
Placebo;C4591001 1013 10131746;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1013 10131832;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 1015 10151134;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1016 10161126;Dose 2 all-available efficacy   Evaluable efficacy (7 days);Dose 2 all-available efficacy   ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;    Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1016 10161167;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 1016 10161348;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1018 10181036;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1018 10181313;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1019 10191098;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1027 10271105;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1028 10281026;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Had other important protocol deviations on or prior to 7 days after Dose 2;;
Placebo;C4591001 1028 10281241;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Had other important protocol deviations on or prior to 7 days after Dose 2;;
Placebo;C4591001 1028 10281285;Dose 2 all-available efficacy   Evaluable efficacy (7 days);Dose 2 all-available efficacy   ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;    Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1028 10281294;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1036 10361128;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1037 10371077;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1038 10381057;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 1039 10391021;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1039 10391080;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1039 10391244;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1042 10421250;Dose 2 all-available efficacy   Evaluable efficacy (7 days);Dose 2 all-available efficacy   ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;    Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1044 10441152;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);"Randomized but did not meet all eligibility criteria; had other important protocol deviations on or prior to 7 days after Dose 2";;
Placebo;C4591001 1044 10441287;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1046 10461040;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1046 10461093;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 1046 10461099;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1046 10461140;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1046 10461318;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 1047 10471176;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 1047 10471221;Dose 2 all-available efficacy Evaluable efficacy (7 days)  ;Dose 2 all-available efficacy ;;Evaluable efficacy (7 days)  ;Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);  
Placebo;C4591001 1047 10471314;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1052 10521054;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1052 10521057;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1052 10521058;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1054 10541023;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1054 10541150;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1055 10551145;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1056 10561098;Evaluable efficacy (7 days)  ;;;Evaluable efficacy (7 days)  ;Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);  ;
Placebo;C4591001 1056 10561129;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1056 10561152;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1056 10561192;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 1056 10561194;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 1056 10561226;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 1056 10561320;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 1056 10561354;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 1056 10561372;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1056 10561384;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 1056 10561395;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1056 10561396;Evaluable efficacy (7 days)  ;;;Evaluable efficacy (7 days)  ;Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);  ;
Placebo;C4591001 1056 10561400;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 1056 10561403;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 1056 10561414;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1056 10561554;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1056 10561591;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1056 10561636;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1057 10571031;Dose 1 all-available efficacy Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 1 all-available efficacy ;Dose 2 all-available efficacy ;Evaluable efficacy (7 days);Did not receive at least 1 vaccination;  Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1)
Placebo;C4591001 1057 10571211;Dose 1 all-available efficacy Dose 2 all-available efficacy   Evaluable efficacy (7 days);Dose 1 all-available efficacy ;Dose 2 all-available efficacy   ;Evaluable efficacy (7 days);Did not receive at least 1 vaccination;  Did not receive 2 vaccinations;    Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1)
Placebo;C4591001 1057 10571215;Dose 1 all-available efficacy Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 1 all-available efficacy ;Dose 2 all-available efficacy ;Evaluable efficacy (7 days);Did not receive at least 1 vaccination;  Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1)
Placebo;C4591001 1057 10571248;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1057 10571268;Dose 1 all-available efficacy Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 1 all-available efficacy ;Dose 2 all-available efficacy ;Evaluable efficacy (7 days);Did not receive at least 1 vaccination;  Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1)
Placebo;C4591001 1066 10661396;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1068 10681010;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Had other important protocol deviations on or prior to 7 days after Dose 2;;
Placebo;C4591001 1071 10711162;Dose 1 all-available efficacy Dose 2 all-available efficacy Evaluable efficacy (7 days)  ;Dose 1 all-available efficacy ;Dose 2 all-available efficacy ;Evaluable efficacy (7 days)  ;Did not receive at least 1 vaccination;  Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1)
Placebo;C4591001 1071 10711185;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1071 10711211;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1071 10711237;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1072 10721051;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1079 10791082;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 1079 10791130;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1079 10791143;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 1079 10791162;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 1079 10791253;Dose 2 all-available efficacy Evaluable efficacy (7 days)  ;Dose 2 all-available efficacy ;;Evaluable efficacy (7 days)  ;Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);  
Placebo;C4591001 1079 10791267;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 1082 10821013;Dose 1 all-available efficacy Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 1 all-available efficacy ;Dose 2 all-available efficacy ;Evaluable efficacy (7 days);Did not receive at least 1 vaccination;  Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1)
Placebo;C4591001 1082 10821077;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1082 10821221;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1083 10831029;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1083 10831060;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1084 10841057;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1085 10851286;Dose 2 all-available efficacy   Evaluable efficacy (7 days);Dose 2 all-available efficacy   ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;    Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1087 10871089;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1087 10871186;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 1087 10871354;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1087 10871356;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1088 10881080;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 1089 10891076;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1090 10901068;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1090 10901245;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 1090 10901334;Evaluable efficacy (7 days)    ;;;Evaluable efficacy (7 days)    ;"Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);   had other important protocol deviations on or prior to 7 days after Dose 2";;
Placebo;C4591001 1090 10901379;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1090 10901507;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1090 10901516;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 1091 10911014;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Had other important protocol deviations on or prior to 7 days after Dose 2;;
Placebo;C4591001 1091 10911083;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1091 10911291;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 1091 10911352;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1092 10921080;Dose 2 all-available efficacy Evaluable efficacy (7 days)  ;Dose 2 all-available efficacy ;;Evaluable efficacy (7 days)  ;Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);  
Placebo;C4591001 1092 10921158;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Had other important protocol deviations on or prior to 7 days after Dose 2;;
Placebo;C4591001 1092 10921175;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 1093 10931072;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1093 10931094;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1094 10941155;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 1095 10951056;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1095 10951144;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 1095 10951197;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 1096 10961031;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1096 10961081;Dose 2 all-available efficacy Evaluable efficacy (7 days)  ;Dose 2 all-available efficacy ;;Evaluable efficacy (7 days)  ;Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);  
Placebo;C4591001 1096 10961195;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Had other important protocol deviations on or prior to 7 days after Dose 2;;
Placebo;C4591001 1096 10961276;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1096 10961321;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1096 10961345;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 1096 10961388;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1097 10971085;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 1098 10981001;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1098 10981155;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);"Randomized but did not meet all eligibility criteria; had other important protocol deviations on or prior to 7 days after Dose 2";;
Placebo;C4591001 1098 10981168;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);"Randomized but did not meet all eligibility criteria; had other important protocol deviations on or prior to 7 days after Dose 2";;
Placebo;C4591001 1098 10981219;Dose 2 all-available efficacy Evaluable efficacy (7 days)  ;Dose 2 all-available efficacy ;;Evaluable efficacy (7 days)  ;Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);  
Placebo;C4591001 1101 11011024;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1107 11071160;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 1107 11071178;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 1109 11091068;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1109 11091127;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1109 11091335;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1109 11091478;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1109 11091515;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1109 11091518;Evaluable efficacy (7 days)  ;;;Evaluable efficacy (7 days)  ;Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);  ;
Placebo;C4591001 1109 11091526;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 1109 11091547;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1109 11091556;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1110 11101038;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1110 11101072;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 1110 11101085;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1110 11101110;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1110 11101155;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1110 11101156;Dose 2 all-available efficacy   Evaluable efficacy (7 days);Dose 2 all-available efficacy   ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;    Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1110 11101229;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1110 11101247;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1110 11101250;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1110 11101342;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1111 11111104;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 1111 11111139;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 1114 11141065;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 1116 11161292;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1117 11171186;Dose 2 all-available efficacy   Evaluable efficacy (7 days);Dose 2 all-available efficacy   ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;    Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1117 11171190;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1120 11201013;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1120 11201038;Dose 1 all-available efficacy Dose 2 all-available efficacy Evaluable efficacy (7 days) ;Dose 1 all-available efficacy ;Dose 2 all-available efficacy ;Evaluable efficacy (7 days) ;Did not receive at least 1 vaccination;  Did not receive 2 vaccinations;"  Randomized but did not meet all eligibility criteria; did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1)"
Placebo;C4591001 1120 11201085;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1120 11201104;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1120 11201249;Dose 2 all-available efficacy Evaluable efficacy (7 days)  ;Dose 2 all-available efficacy ;;Evaluable efficacy (7 days)  ;Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);  
Placebo;C4591001 1120 11201252;Dose 1 all-available efficacy Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 1 all-available efficacy ;Dose 2 all-available efficacy ;Evaluable efficacy (7 days);Did not receive at least 1 vaccination;  Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1)
Placebo;C4591001 1122 11221006;Dose 1 all-available efficacy Dose 2 all-available efficacy Evaluable efficacy (7 days) ;Dose 1 all-available efficacy ;Dose 2 all-available efficacy ;Evaluable efficacy (7 days) ;Did not receive at least 1 vaccination;  Did not receive 2 vaccinations;"  Randomized but did not meet all eligibility criteria; did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1)"
Placebo;C4591001 1123 11231290;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1123 11231313;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1124 11241003;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 1124 11241084;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1125 11251019;Dose 2 all-available efficacy   Evaluable efficacy (7 days);Dose 2 all-available efficacy   ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;    Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1125 11251160;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1125 11251238;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1126 11261074;Dose 1 all-available efficacy Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 1 all-available efficacy ;Dose 2 all-available efficacy ;Evaluable efficacy (7 days);Did not receive at least 1 vaccination;  Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1)
Placebo;C4591001 1127 11271099;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1128 11281012;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 1128 11281093;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 1128 11281146;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1128 11281368;Dose 2 all-available efficacy   Evaluable efficacy (7 days);Dose 2 all-available efficacy   ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;    Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1129 11291048;Dose 1 all-available efficacy Dose 2 all-available efficacy Evaluable efficacy (7 days) ;Dose 1 all-available efficacy ;Dose 2 all-available efficacy ;Evaluable efficacy (7 days) ;Did not receive at least 1 vaccination;  Did not receive 2 vaccinations;"  Randomized but did not meet all eligibility criteria; did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1)"
Placebo;C4591001 1129 11291165;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 1131 11311193;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1133 11331037;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1133 11331042;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1133 11331059;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 1133 11331087;Dose 2 all-available efficacy Evaluable efficacy (7 days)  ;Dose 2 all-available efficacy ;;Evaluable efficacy (7 days)  ;Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);  
Placebo;C4591001 1133 11331120;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 1133 11331138;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1133 11331162;Dose 1 all-available efficacy Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 1 all-available efficacy ;Dose 2 all-available efficacy ;Evaluable efficacy (7 days);Did not receive at least 1 vaccination;  Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1)
Placebo;C4591001 1133 11331170;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1133 11331207;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1133 11331291;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1133 11331338;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1133 11331510;Dose 2 all-available efficacy   Evaluable efficacy (7 days);Dose 2 all-available efficacy   ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;    Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1133 11331512;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1133 11331562;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1133 11331568;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1133 11331583;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1133 11331598;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1133 11331635;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1135 11351132;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 1135 11351200;Dose 2 all-available efficacy   Evaluable efficacy (7 days);Dose 2 all-available efficacy   ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;    Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1135 11351212;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1135 11351420;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1136 11361045;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1136 11361095;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 1140 11401306;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1141 11411146;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1142 11421303;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 1145 11451063;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 1147 11471035;Dose 2 all-available efficacy   Evaluable efficacy (7 days);Dose 2 all-available efficacy   ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;    Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1149 11491065;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1149 11491066;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1149 11491108;Dose 1 all-available efficacy Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 1 all-available efficacy ;Dose 2 all-available efficacy ;Evaluable efficacy (7 days);Did not receive at least 1 vaccination;  Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1)
Placebo;C4591001 1149 11491172;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 1149 11491230;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1149 11491344;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1152 11521030;Dose 2 all-available efficacy Evaluable efficacy (7 days)  ;Dose 2 all-available efficacy ;;Evaluable efficacy (7 days)  ;Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);  
Placebo;C4591001 1152 11521085;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1156 11561015;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1156 11561033;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1156 11561200;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 1157 11571003;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1157 11571135;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1157 11571156;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 1161 11611004;Dose 1 all-available efficacy Dose 2 all-available efficacy Evaluable efficacy (7 days)     ;Dose 1 all-available efficacy ;Dose 2 all-available efficacy ;Evaluable efficacy (7 days)     ;Data considered potentially unreliable due to lack of PI oversight identified as significant quality event; Data considered potentially unreliable due to lack of PI oversight identified as significant quality event;" Data considered potentially unreliable due to lack of PI oversight identified as significant quality event; did not receive all   vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1); had other important protocol deviations on or prior to 7 days after Dose 2"
Placebo;C4591001 1161 11611005;Dose 1 all-available efficacy Dose 2 all-available efficacy  Evaluable efficacy (7 days)  ;Dose 1 all-available efficacy ;Dose 2 all-available efficacy  ;Evaluable efficacy (7 days)  ;Data considered potentially unreliable due to lack of PI oversight identified as significant quality event;" Did not receive 2 vaccinations; data considered potentially unreliable due to lack of PI oversight identified as significant quality event";" Data considered potentially unreliable due to lack of PI oversight identified as significant quality event; did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1)"
Placebo;C4591001 1161 11611007;Dose 1 all-available efficacy Dose 2 all-available efficacy  Evaluable efficacy (7 days)  ;Dose 1 all-available efficacy ;Dose 2 all-available efficacy  ;Evaluable efficacy (7 days)  ;Data considered potentially unreliable due to lack of PI oversight identified as significant quality event;" Did not receive 2 vaccinations; data considered potentially unreliable due to lack of PI oversight identified as significant quality event";" Data considered potentially unreliable due to lack of PI oversight identified as significant quality event; did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1)"
Placebo;C4591001 1161 11611008;Dose 1 all-available efficacy Dose 2 all-available efficacy  Evaluable efficacy (7 days)     ;Dose 1 all-available efficacy ;Dose 2 all-available efficacy  ;Evaluable efficacy (7 days)     ;Data considered potentially unreliable due to lack of PI oversight identified as significant quality event;" Did not receive 2 vaccinations; data considered potentially unreliable due to lack of PI oversight identified as significant quality event";" Randomized but did not meet all eligibility criteria; data considered potentially unreliable due to lack of PI oversight identified as significant quality event; did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1)"
Placebo;C4591001 1161 11611010;Dose 1 all-available efficacy Dose 2 all-available efficacy  Evaluable efficacy (7 days)  ;Dose 1 all-available efficacy ;Dose 2 all-available efficacy  ;Evaluable efficacy (7 days)  ;Data considered potentially unreliable due to lack of PI oversight identified as significant quality event;" Did not receive 2 vaccinations; data considered potentially unreliable due to lack of PI oversight identified as significant quality event";" Data considered potentially unreliable due to lack of PI oversight identified as significant quality event; did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1)"
Placebo;C4591001 1161 11611015;Dose 1 all-available efficacy Dose 2 all-available efficacy Evaluable efficacy (7 days)   ;Dose 1 all-available efficacy ;Dose 2 all-available efficacy ;Evaluable efficacy (7 days)   ;Data considered potentially unreliable due to lack of PI oversight identified as significant quality event; Data considered potentially unreliable due to lack of PI oversight identified as significant quality event;" Data considered potentially unreliable due to lack of PI oversight identified as significant quality event; did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1); had other important protocol deviations on or prior to 7 days after Dose 2"
Placebo;C4591001 1161 11611016;Dose 1 all-available efficacy Dose 2 all-available efficacy Evaluable efficacy (7 days)   ;Dose 1 all-available efficacy ;Dose 2 all-available efficacy ;Evaluable efficacy (7 days)   ;Data considered potentially unreliable due to lack of PI oversight identified as significant quality event; Data considered potentially unreliable due to lack of PI oversight identified as significant quality event;" Data considered potentially unreliable due to lack of PI oversight identified as significant quality event; did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1); had other important protocol deviations on or prior to 7 days after Dose 2"
Placebo;C4591001 1161 11611018;Dose 1 all-available efficacy   Dose 2 all-available efficacy  Evaluable efficacy (7 days)   ;Dose 1 all-available efficacy   ;Dose 2 all-available efficacy  ;Evaluable efficacy (7 days)   ;Data considered potentially unreliable due to lack of PI oversight identified as significant quality event;"   Did not receive 2 vaccinations; data considered potentially unreliable due to lack of PI oversight identified as significant quality event";" Randomized but did not meet all eligibility criteria; data considered potentially unreliable due to lack of PI oversight identified as significant quality event; did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1)"
Placebo;C4591001 1161 11611023;Dose 1 all-available efficacy Dose 2 all-available efficacy  Evaluable efficacy (7 days)   ;Dose 1 all-available efficacy ;Dose 2 all-available efficacy  ;Evaluable efficacy (7 days)   ;Data considered potentially unreliable due to lack of PI oversight identified as significant quality event;" Did not receive 2 vaccinations; data considered potentially unreliable due to lack of PI oversight identified as significant quality event";" Randomized but did not meet all eligibility criteria; data considered potentially unreliable due to lack of PI oversight identified as significant quality event; did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1)"
Placebo;C4591001 1161 11611024;Dose 1 all-available efficacy Dose 2 all-available efficacy  Evaluable efficacy (7 days)  ;Dose 1 all-available efficacy ;Dose 2 all-available efficacy  ;Evaluable efficacy (7 days)  ;Data considered potentially unreliable due to lack of PI oversight identified as significant quality event;" Did not receive 2 vaccinations; data considered potentially unreliable due to lack of PI oversight identified as significant quality event";" Data considered potentially unreliable due to lack of PI oversight identified as significant quality event; did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1)"
Placebo;C4591001 1161 11611027;Dose 1 all-available efficacy Dose 2 all-available efficacy   Evaluable efficacy (7 days)   ;Dose 1 all-available efficacy ;Dose 2 all-available efficacy   ;Evaluable efficacy (7 days)   ;Data considered potentially unreliable due to lack of PI oversight identified as significant quality event; Data considered potentially unreliable due to lack of PI oversight identified as significant quality event;"   Data considered potentially unreliable due to lack of PI oversight identified as significant quality event; did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1); had other important protocol deviations on or prior to 7 days after Dose 2"
Placebo;C4591001 1161 11611028;Dose 1 all-available efficacy Dose 2 all-available efficacy Evaluable efficacy (7 days)   ;Dose 1 all-available efficacy ;Dose 2 all-available efficacy ;Evaluable efficacy (7 days)   ;Data considered potentially unreliable due to lack of PI oversight identified as significant quality event; Data considered potentially unreliable due to lack of PI oversight identified as significant quality event;" Data considered potentially unreliable due to lack of PI oversight identified as significant quality event; did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1); had other important protocol deviations on or prior to 7 days after Dose 2"
Placebo;C4591001 1161 11611033;Dose 1 all-available efficacy Dose 2 all-available efficacy Evaluable efficacy (7 days)   ;Dose 1 all-available efficacy ;Dose 2 all-available efficacy ;Evaluable efficacy (7 days)   ;Data considered potentially unreliable due to lack of PI oversight identified as significant quality event; Data considered potentially unreliable due to lack of PI oversight identified as significant quality event;" Data considered potentially unreliable due to lack of PI oversight identified as significant quality event; did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1); had other important protocol deviations on or prior to 7 days after Dose 2"
Placebo;C4591001 1161 11611040;Dose 1 all-available efficacy Dose 2 all-available efficacy Evaluable efficacy (7 days)     ;Dose 1 all-available efficacy ;Dose 2 all-available efficacy ;Evaluable efficacy (7 days)     ;Data considered potentially unreliable due to lack of PI oversight identified as significant quality event; Data considered potentially unreliable due to lack of PI oversight identified as significant quality event;" Data considered potentially unreliable due to lack of PI oversight identified as significant quality event; did not receive all vaccinations as randomized or did not receive Dose 2 within the   predefined window (19-42 days after Dose 1); had other important protocol deviations on or prior to 7 days after Dose 2"
Placebo;C4591001 1162 11621024;Dose 1 all-available efficacy Dose 2 all-available efficacy Evaluable efficacy (7 days) ;Dose 1 all-available efficacy ;Dose 2 all-available efficacy ;Evaluable efficacy (7 days) ;Did not receive at least 1 vaccination;  Did not receive 2 vaccinations;"  Randomized but did not meet all eligibility criteria; did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1)"
Placebo;C4591001 1162 11621217;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 1162 11621294;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1162 11621310;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1162 11621356;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1162 11621514;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1162 11621515;Dose 2 all-available efficacy   Evaluable efficacy (7 days);Dose 2 all-available efficacy   ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;    Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1163 11631039;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Had other important protocol deviations on or prior to 7 days after Dose 2;;
Placebo;C4591001 1163 11631059;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1163 11631064;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Had other important protocol deviations on or prior to 7 days after Dose 2;;
Placebo;C4591001 1163 11631096;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Had other important protocol deviations on or prior to 7 days after Dose 2;;
Placebo;C4591001 1166 11661047;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1166 11661091;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 1167 11671003;Dose 1 all-available efficacy Dose 2 all-available efficacy Evaluable efficacy (7 days) ;Dose 1 all-available efficacy ;Dose 2 all-available efficacy ;Evaluable efficacy (7 days) ;Did not receive at least 1 vaccination;  Did not receive 2 vaccinations;"  Randomized but did not meet all eligibility criteria; did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1)"
Placebo;C4591001 1167 11671223;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 1168 11681070;Evaluable efficacy (7 days)  ;;;Evaluable efficacy (7 days)  ;Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);  ;
Placebo;C4591001 1168 11681104;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1168 11681227;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1169 11691058;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1170 11701015;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 1170 11701059;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 1170 11701064;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 1170 11701117;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 1170 11701201;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 1170 11701308;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 1170 11701311;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1170 11701334;Evaluable efficacy (7 days)  ;;;Evaluable efficacy (7 days)  ;Had other important protocol deviations on or prior to 7 days after Dose 2;  ;
Placebo;C4591001 1170 11701364;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 1170 11701427;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1170 11701453;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 1171 11711101;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 1171 11711131;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1171 11711154;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 1171 11711159;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1171 11711189;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 1171 11711216;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 1171 11711221;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 1171 11711224;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 1171 11711226;Evaluable efficacy (7 days)  ;;;Evaluable efficacy (7 days)  ;Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);  ;
Placebo;C4591001 1171 11711228;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 1171 11711231;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 1171 11711241;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 1171 11711247;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 1171 11711248;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 1171 11711250;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 1171 11711301;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1177 11771139;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1177 11771292;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 1185 11851055;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Had other important protocol deviations on or prior to 7 days after Dose 2;;
Placebo;C4591001 1197 11971040;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 1197 11971041;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 1203 12031048;Evaluable efficacy (7 days)  ;;;Evaluable efficacy (7 days)  ;Had other important protocol deviations on or prior to 7 days after Dose 2;  ;
Placebo;C4591001 1204 12041197;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1204 12041280;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Had other important protocol deviations on or prior to 7 days after Dose 2;;
Placebo;C4591001 1205 12051078;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1210 12101019;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1210 12101053;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1213 12131046;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1214 12141020;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 1214 12141038;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 1214 12141048;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 1217 12171031;Dose 2 all-available efficacy   Evaluable efficacy (7 days);Dose 2 all-available efficacy   ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;    Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1217 12171044;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1218 12181036;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Unblinded prior to 7 days post Dose 2;  Unblinded prior to 7 days post Dose 2; 
Placebo;C4591001 1218 12181041;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1218 12181042;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1218 12181044;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Unblinded prior to 7 days post Dose 2;  Unblinded prior to 7 days post Dose 2; 
Placebo;C4591001 1218 12181048;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1218 12181050;Dose 2 all-available efficacy Evaluable efficacy (7 days)  ;Dose 2 all-available efficacy ;;Evaluable efficacy (7 days)  ;Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);  
Placebo;C4591001 1218 12181052;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1218 12181057;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1219 12191056;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1219 12191062;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1220 12201041;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 1220 12201051;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Unblinded prior to 7 days post Dose 2;  Unblinded prior to 7 days post Dose 2; 
Placebo;C4591001 1220 12201056;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Unblinded prior to 7 days post Dose 2;  Unblinded prior to 7 days post Dose 2; 
Placebo;C4591001 1220 12201061;Dose 2 all-available efficacy Evaluable efficacy (7 days)  ;Dose 2 all-available efficacy ;;Evaluable efficacy (7 days)  ;Unblinded prior to 7 days post Dose 2;  Unblinded prior to 7 days post Dose 2;   
Placebo;C4591001 1220 12201065;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1221 12211002;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Had other important protocol deviations on or prior to 7 days after Dose 2;;
Placebo;C4591001 1221 12211007;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 1221 12211053;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Unblinded prior to 7 days post Dose 2;  Unblinded prior to 7 days post Dose 2; 
Placebo;C4591001 1221 12211072;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Unblinded prior to 7 days post Dose 2;  Unblinded prior to 7 days post Dose 2; 
Placebo;C4591001 1221 12211078;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1223 12231174;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1224 12241009;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1224 12241065;Dose 2 all-available efficacy   Evaluable efficacy (7 days);Dose 2 all-available efficacy   ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;    Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1224 12241158;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);"Randomized but did not meet all eligibility criteria; had other important protocol deviations on or prior to 7 days after Dose 2";;
Placebo;C4591001 1224 12241167;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1224 12241170;Dose 1 all-available efficacy Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 1 all-available efficacy ;Dose 2 all-available efficacy ;Evaluable efficacy (7 days);Did not receive at least 1 vaccination;  Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1)
Placebo;C4591001 1224 12241175;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1226 12261380;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 1226 12261391;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 1226 12261894;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1226 12262063;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 1226 12262108;Dose 2 all-available efficacy   Evaluable efficacy (7 days);Dose 2 all-available efficacy   ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;    Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1226 12262189;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1226 12262267;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1230 12301065;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 1230 12301150;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1231 12311031;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1231 12311054;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1231 12311087;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1231 12311088;Dose 2 all-available efficacy   Evaluable efficacy (7 days) ;Dose 2 all-available efficacy   ;;Evaluable efficacy (7 days) ;Did not receive 2 vaccinations;"    Randomized but did not meet all eligibility criteria; did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1)";
Placebo;C4591001 1231 12311147;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1231 12311191;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1231 12311195;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1231 12311301;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 1231 12311356;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1231 12311374;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1231 12311391;Dose 2 all-available efficacy Evaluable efficacy (7 days)  ;Dose 2 all-available efficacy ;;Evaluable efficacy (7 days)  ;Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);  
Placebo;C4591001 1231 12311402;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1231 12311420;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 1231 12311431;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1231 12311441;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1231 12311473;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1231 12311516;Dose 1 all-available efficacy Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 1 all-available efficacy ;Dose 2 all-available efficacy ;Evaluable efficacy (7 days);Did not receive at least 1 vaccination;  Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1)
Placebo;C4591001 1231 12311559;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1231 12311568;Dose 2 all-available efficacy   Evaluable efficacy (7 days);Dose 2 all-available efficacy   ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;    Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1231 12311656;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1231 12311816;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1231 12311858;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 1231 12311885;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Randomized but did not meet all eligibility criteria; ;
Placebo;C4591001 1231 12311926;Dose 1 all-available efficacy Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 1 all-available efficacy ;Dose 2 all-available efficacy ;Evaluable efficacy (7 days);Did not receive at least 1 vaccination;  Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1)
Placebo;C4591001 1231 12312176;Dose 1 all-available efficacy Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 1 all-available efficacy ;Dose 2 all-available efficacy ;Evaluable efficacy (7 days);Did not receive at least 1 vaccination;  Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1)
Placebo;C4591001 1231 12312244;Dose 2 all-available efficacy Evaluable efficacy (7 days)  ;Dose 2 all-available efficacy ;;Evaluable efficacy (7 days)  ;Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);  
Placebo;C4591001 1231 12312320;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1231 12312326;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1231 12312334;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1231 12312426;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 1231 12312439;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 1231 12312483;Dose 1 all-available efficacy Dose 2 all-available efficacy Evaluable efficacy (7 days) ;Dose 1 all-available efficacy ;Dose 2 all-available efficacy ;Evaluable efficacy (7 days) ;Did not receive at least 1 vaccination;  Did not receive 2 vaccinations;"  Randomized but did not meet all eligibility criteria; did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1)"
Placebo;C4591001 1231 12312594;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1231 12312623;Dose 2 all-available efficacy   Evaluable efficacy (7 days);Dose 2 all-available efficacy   ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;    Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1231 12312660;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1231 12312752;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1231 12312763;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1231 12312848;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1231 12312868;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 1231 12312916;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1231 12313068;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1231 12313069;Dose 2 all-available efficacy   Evaluable efficacy (7 days);Dose 2 all-available efficacy   ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;    Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1231 12313098;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 1231 12313115;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1231 12313125;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1231 12313211;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1231 12313376;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1231 12313395;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1231 12313443;Dose 1 all-available efficacy Dose 2 all-available efficacy Evaluable efficacy (7 days)  ;Dose 1 all-available efficacy ;Dose 2 all-available efficacy ;Evaluable efficacy (7 days)  ;Did not receive at least 1 vaccination;  Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1)
Placebo;C4591001 1231 12313454;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1231 12313510;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1231 12313516;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 1231 12313527;Dose 1 all-available efficacy Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 1 all-available efficacy ;Dose 2 all-available efficacy ;Evaluable efficacy (7 days);Did not receive at least 1 vaccination;  Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1)
Placebo;C4591001 1231 12313657;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1231 12313758;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1231 12313939;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 1231 12314134;Dose 2 all-available efficacy Evaluable efficacy (7 days)  ;Dose 2 all-available efficacy ;;Evaluable efficacy (7 days)  ;Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);  
Placebo;C4591001 1231 12314266;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1231 12314381;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1231 12314492;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1231 12314679;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 1231 12314738;Dose 1 all-available efficacy Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 1 all-available efficacy ;Dose 2 all-available efficacy ;Evaluable efficacy (7 days);Did not receive at least 1 vaccination;  Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1)
Placebo;C4591001 1231 12314848;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1231 12314857;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 1231 12314923;Dose 2 all-available efficacy Evaluable efficacy (7 days)  ;Dose 2 all-available efficacy ;;Evaluable efficacy (7 days)  ;Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);  
Placebo;C4591001 1231 12314984;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1231 12315322;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 1231 12315357;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1231 12315681;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 1232 12321015;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1232 12321100;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1232 12321142;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1232 12321213;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1232 12321220;Evaluable efficacy (7 days)  ;;;Evaluable efficacy (7 days)  ;Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);  ;
Placebo;C4591001 1232 12321244;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1232 12321287;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1232 12321310;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 1232 12321378;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 1232 12321400;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1232 12321429;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1235 12351027;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1235 12351071;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1235 12351167;Dose 1 all-available efficacy   Dose 2 all-available efficacy Evaluable efficacy (7 days) ;Dose 1 all-available efficacy   ;Dose 2 all-available efficacy ;Evaluable efficacy (7 days) ;Did not receive at least 1 vaccination;    Did not receive 2 vaccinations;"  Randomized but did not meet all eligibility criteria; did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1)"
Placebo;C4591001 1235 12351187;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1241 12411260;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1241 12411273;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 1241 12411279;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1241 12411688;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1241 12411695;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1241 12412355;Dose 2 all-available efficacy   Evaluable efficacy (7 days);Dose 2 all-available efficacy   ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;    Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1247 12471244;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Had other important protocol deviations on or prior to 7 days after Dose 2;;
Placebo;C4591001 1248 12481018;Dose 1 all-available efficacy Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 1 all-available efficacy ;Dose 2 all-available efficacy ;Evaluable efficacy (7 days);Did not receive at least 1 vaccination;  Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1)
Placebo;C4591001 1248 12481046;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1248 12481060;Dose 1 all-available efficacy Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 1 all-available efficacy ;Dose 2 all-available efficacy ;Evaluable efficacy (7 days);Did not receive at least 1 vaccination;  Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1)
Placebo;C4591001 1248 12481110;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1248 12481170;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 1248 12481199;Dose 2 all-available efficacy Evaluable efficacy (7 days)  ;Dose 2 all-available efficacy ;;Evaluable efficacy (7 days)  ;Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);  
Placebo;C4591001 1248 12481218;Dose 1 all-available efficacy Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 1 all-available efficacy ;Dose 2 all-available efficacy ;Evaluable efficacy (7 days);Did not receive at least 1 vaccination;  Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1)
Placebo;C4591001 1251 12511207;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1254 12541116;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1254 12541145;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Had other important protocol deviations on or prior to 7 days after Dose 2;;
Placebo;C4591001 1260 12601070;Dose 1 all-available efficacy Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 1 all-available efficacy ;Dose 2 all-available efficacy ;Evaluable efficacy (7 days);Did not receive at least 1 vaccination;  Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1)
Placebo;C4591001 1264 12641018;Dose 1 all-available efficacy Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 1 all-available efficacy ;Dose 2 all-available efficacy ;Evaluable efficacy (7 days);Did not receive at least 1 vaccination;  Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1)
Placebo;C4591001 1269 12691081;Evaluable efficacy (7 days)  ;;;Evaluable efficacy (7 days)  ;Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);  ;
Placebo;C4591001 1270 12701056;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 1270 12701170;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 4444 44441007;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 4444 44441025;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 4444 44441044;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 4444 44441048;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 4444 44441079;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 4444 44441179;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 4444 44441522;Dose 2 all-available efficacy Evaluable efficacy (7 days)  ;Dose 2 all-available efficacy ;;Evaluable efficacy (7 days)  ;Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);  
Placebo;C4591001 4444 44441560;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 4444 44441912;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 4444 44441931;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 4444 44441938;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 4444 44441979;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 4444 44442059;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 4444 44442069;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 4444 44442071;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 4444 44442072;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 4444 44442077;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 4444 44442081;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 4444 44442086;Evaluable efficacy (7 days)  ;;;Evaluable efficacy (7 days)  ;Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);  ;
Placebo;C4591001 4444 44442090;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 4444 44442091;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 4444 44442095;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 4444 44442100;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 4444 44442101;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 4444 44442105;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 4444 44442107;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 4444 44442115;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 4444 44442117;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 4444 44442119;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 4444 44442140;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 4444 44442142;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 4444 44442151;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 4444 44442156;Evaluable efficacy (7 days)  ;;;Evaluable efficacy (7 days)  ;Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);  ;
Placebo;C4591001 4444 44442160;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 4444 44442161;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 4444 44442162;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 4444 44442165;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 4444 44442168;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 4444 44442170;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 4444 44442196;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 4444 44442205;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 4444 44442212;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 4444 44442215;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 4444 44442232;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 4444 44442233;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 4444 44442237;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 4444 44442249;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 4444 44442253;Evaluable efficacy (7 days)  ;;;Evaluable efficacy (7 days)  ;Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);  ;
Placebo;C4591001 4444 44442256;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 4444 44442263;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 4444 44442274;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 4444 44442279;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 4444 44442281;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 4444 44442284;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 4444 44442285;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 4444 44442292;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 4444 44442293;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 4444 44442294;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 4444 44442297;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 4444 44442301;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 4444 44442303;Evaluable efficacy (7 days)  ;;;Evaluable efficacy (7 days)  ;Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);  ;
Placebo;C4591001 4444 44442304;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 4444 44442307;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 4444 44442308;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 4444 44442310;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 4444 44442315;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 4444 44442322;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 1005 10051338;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 1006 10061020;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1007 10071114;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1007 10071315;Evaluable efficacy (7 days)  ;;;Evaluable efficacy (7 days)  ;"Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1); had other important protocol deviations on or prior to 7 days after Dose 2";;
Placebo;C4591001 1007 10071347;Dose 2 all-available efficacy Evaluable efficacy (7 days)  ;Dose 2 all-available efficacy ;;Evaluable efficacy (7 days)  ;Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);  
Placebo;C4591001 1008 10081639;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1008 10081725;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1009 10091020;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1009 10091089;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 1009 10091157;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1011 10111029;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 1011 10111085;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 1011 10111086;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 1013 10131097;Dose 1 all-available efficacy Dose 2 all-available efficacy Evaluable efficacy (7 days)  ;Dose 1 all-available efficacy ;Dose 2 all-available efficacy ;Evaluable efficacy (7 days)  ;Did not receive at least 1 vaccination;  Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1)
Placebo;C4591001 1013 10131192;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1016 10161166;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 1016 10161282;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 1019 10191033;Dose 1 all-available efficacy Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 1 all-available efficacy ;Dose 2 all-available efficacy ;Evaluable efficacy (7 days);Did not receive at least 1 vaccination;  Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1)
Placebo;C4591001 1019 10191300;Dose 1 all-available efficacy Dose 2 all-available efficacy Evaluable efficacy (7 days) ;Dose 1 all-available efficacy ;Dose 2 all-available efficacy ;Evaluable efficacy (7 days) ;Did not receive at least 1 vaccination;  Did not receive 2 vaccinations;"  Randomized but did not meet all eligibility criteria; did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1)"
Placebo;C4591001 1022 10221015;Dose 1 all-available efficacy Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 1 all-available efficacy ;Dose 2 all-available efficacy ;Evaluable efficacy (7 days);Did not receive at least 1 vaccination;  Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1)
Placebo;C4591001 1022 10221057;Dose 1 all-available efficacy   Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 1 all-available efficacy   ;Dose 2 all-available efficacy ;Evaluable efficacy (7 days);Did not receive at least 1 vaccination;    Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1)
Placebo;C4591001 1024 10241130;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1036 10361133;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1037 10371117;Dose 1 all-available efficacy Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 1 all-available efficacy ;Dose 2 all-available efficacy ;Evaluable efficacy (7 days);Did not receive at least 1 vaccination;  Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1)
Placebo;C4591001 1037 10371195;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 1037 10371303;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 1037 10371333;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Randomized but did not meet all eligibility criteria; ;
Placebo;C4591001 1038 10381056;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 1042 10421010;Dose 2 all-available efficacy Evaluable efficacy (7 days)  ;Dose 2 all-available efficacy ;;Evaluable efficacy (7 days)  ;Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);  
Placebo;C4591001 1044 10441116;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 1046 10461126;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 1046 10461259;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1046 10461301;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 1047 10471252;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1052 10521020;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1054 10541024;Evaluable efficacy (7 days)  ;;;Evaluable efficacy (7 days)  ;"Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1); had other important protocol deviations on or prior to 7 days after Dose 2";;
Placebo;C4591001 1054 10541186;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1055 10551039;Dose 2 all-available efficacy Evaluable efficacy (7 days)  ;Dose 2 all-available efficacy ;;Evaluable efficacy (7 days)  ;Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);  
Placebo;C4591001 1056 10561015;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 1056 10561018;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1056 10561032;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 1056 10561079;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1056 10561099;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 1056 10561232;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 1056 10561275;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1056 10561276;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1056 10561302;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 1056 10561337;Dose 2 all-available efficacy Evaluable efficacy (7 days)  ;Dose 2 all-available efficacy ;;Evaluable efficacy (7 days)  ;Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);  
Placebo;C4591001 1056 10561371;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1056 10561381;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1056 10561415;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 1056 10561426;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1057 10571128;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 1066 10661350;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1068 10681043;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Had other important protocol deviations on or prior to 7 days after Dose 2;;
Placebo;C4591001 1068 10681063;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Had other important protocol deviations on or prior to 7 days after Dose 2;;
Placebo;C4591001 1071 10711049;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 1071 10711063;Dose 2 all-available efficacy Evaluable efficacy (7 days)  ;Dose 2 all-available efficacy ;;Evaluable efficacy (7 days)  ;Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);  
Placebo;C4591001 1071 10711216;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1072 10721037;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 1079 10791057;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1079 10791158;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 1079 10791266;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 1080 10801222;Dose 1 all-available efficacy Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 1 all-available efficacy ;Dose 2 all-available efficacy ;Evaluable efficacy (7 days);Did not receive at least 1 vaccination;  Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1)
Placebo;C4591001 1081 10811093;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Had other important protocol deviations on or prior to 7 days after Dose 2;;
Placebo;C4591001 1082 10821007;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 1082 10821164;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1084 10841006;Evaluable efficacy (7 days)  ;;;Evaluable efficacy (7 days)  ;Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);  ;
Placebo;C4591001 1084 10841366;Dose 1 all-available efficacy Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 1 all-available efficacy ;Dose 2 all-available efficacy ;Evaluable efficacy (7 days);Did not receive at least 1 vaccination;  Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1)
Placebo;C4591001 1087 10871033;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 1087 10871211;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1087 10871228;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1087 10871505;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1087 10871560;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1089 10891004;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 1089 10891344;Dose 2 all-available efficacy Evaluable efficacy (7 days)  ;Dose 2 all-available efficacy ;;Evaluable efficacy (7 days)  ;Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);  
Placebo;C4591001 1090 10901146;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 1090 10901415;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1090 10901519;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 1091 10911006;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 1092 10921123;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 1092 10921191;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1093 10931050;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1093 10931051;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1093 10931128;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1093 10931191;Dose 2 all-available efficacy   Evaluable efficacy (7 days);Dose 2 all-available efficacy   ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;    Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1094 10941080;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1094 10941130;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1094 10941191;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);"Randomized but did not meet all eligibility criteria; had other important protocol deviations on or prior to 7 days after Dose 2";;
Placebo;C4591001 1095 10951107;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Had other important protocol deviations on or prior to 7 days after Dose 2;;
Placebo;C4591001 1096 10961048;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1096 10961082;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1096 10961086;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1096 10961160;Dose 2 all-available efficacy Evaluable efficacy (7 days)  ;Dose 2 all-available efficacy ;;Evaluable efficacy (7 days)  ;Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);  
Placebo;C4591001 1096 10961282;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 1097 10971033;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1097 10971047;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 1097 10971060;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Had other important protocol deviations on or prior to 7 days after Dose 2;;
Placebo;C4591001 1101 11011077;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);"Randomized but did not meet all eligibility criteria; had other important protocol deviations on or prior to 7 days after Dose 2";;
Placebo;C4591001 1107 11071093;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 1109 11091101;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 1109 11091248;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1109 11091313;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 1109 11091407;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 1110 11101241;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1111 11111106;Evaluable efficacy (7 days)  ;;;Evaluable efficacy (7 days)  ;Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);  ;
Placebo;C4591001 1112 11121052;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1112 11121337;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1116 11161118;Dose 1 all-available efficacy Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 1 all-available efficacy ;Dose 2 all-available efficacy ;Evaluable efficacy (7 days);Did not receive at least 1 vaccination;  Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1)
Placebo;C4591001 1116 11161253;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1117 11171040;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 1117 11171052;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 1118 11181065;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1120 11201066;Dose 2 all-available efficacy Evaluable efficacy (7 days)  ;Dose 2 all-available efficacy ;;Evaluable efficacy (7 days)  ;Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);  
Placebo;C4591001 1120 11201073;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1120 11201127;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1120 11201213;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 1120 11201227;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 1120 11201335;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1120 11201351;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1120 11201436;Dose 1 all-available efficacy Dose 2 all-available efficacy Evaluable efficacy (7 days) ;Dose 1 all-available efficacy ;Dose 2 all-available efficacy ;Evaluable efficacy (7 days) ;Did not receive at least 1 vaccination;  Did not receive 2 vaccinations;"  Randomized but did not meet all eligibility criteria; did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1)"
Placebo;C4591001 1124 11241048;Evaluable efficacy (7 days)  ;;;Evaluable efficacy (7 days)  ;Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);  ;
Placebo;C4591001 1125 11251107;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 1125 11251211;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1126 11261147;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Had other important protocol deviations on or prior to 7 days after Dose 2;;
Placebo;C4591001 1127 11271003;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 1128 11281023;Dose 1 all-available efficacy Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 1 all-available efficacy ;Dose 2 all-available efficacy ;Evaluable efficacy (7 days);Did not receive at least 1 vaccination;  Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1)
Placebo;C4591001 1128 11281109;Dose 1 all-available efficacy Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 1 all-available efficacy ;Dose 2 all-available efficacy ;Evaluable efficacy (7 days);Did not receive at least 1 vaccination;  Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1)
Placebo;C4591001 1128 11281138;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Had other important protocol deviations on or prior to 7 days after Dose 2;;
Placebo;C4591001 1129 11291082;Dose 1 all-available efficacy Dose 2 all-available efficacy   Evaluable efficacy (7 days) ;Dose 1 all-available efficacy ;Dose 2 all-available efficacy   ;Evaluable efficacy (7 days) ;Did not receive at least 1 vaccination;  Did not receive 2 vaccinations;"    Randomized but did not meet all eligibility criteria; did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1)"
Placebo;C4591001 1129 11291237;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 1131 11311145;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1131 11311164;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 1133 11331426;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1133 11331469;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 1133 11331481;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1134 11341067;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Randomized but did not meet all eligibility criteria; ;
Placebo;C4591001 1134 11341087;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 1134 11341130;Dose 1 all-available efficacy Dose 2 all-available efficacy   Evaluable efficacy (7 days);Dose 1 all-available efficacy ;Dose 2 all-available efficacy   ;Evaluable efficacy (7 days);Did not receive at least 1 vaccination;  Did not receive 2 vaccinations;    Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1)
Placebo;C4591001 1134 11341339;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 1135 11351128;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 1136 11361104;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 1136 11361105;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 1140 11401035;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1140 11401082;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 1141 11411196;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 1142 11421305;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 1145 11451076;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1147 11471004;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1149 11491100;Dose 1 all-available efficacy   Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 1 all-available efficacy   ;Dose 2 all-available efficacy ;Evaluable efficacy (7 days);Did not receive at least 1 vaccination;    Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1)
Placebo;C4591001 1156 11561044;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1156 11561092;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 1157 11571028;Dose 1 all-available efficacy Dose 2 all-available efficacy Evaluable efficacy (7 days) ;Dose 1 all-available efficacy ;Dose 2 all-available efficacy ;Evaluable efficacy (7 days) ;Did not receive at least 1 vaccination;  Did not receive 2 vaccinations;"  Randomized but did not meet all eligibility criteria; did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1)"
Placebo;C4591001 1157 11571131;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1161 11611003;Dose 1 all-available efficacy Dose 2 all-available efficacy Evaluable efficacy (7 days)     ;Dose 1 all-available efficacy ;Dose 2 all-available efficacy ;Evaluable efficacy (7 days)     ;Data considered potentially unreliable due to lack of PI oversight identified as significant quality event; Data considered potentially unreliable due to lack of PI oversight identified as significant quality event;" Data considered potentially unreliable due to lack of PI oversight identified as significant quality event; did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1); had other important protocol deviations on or prior to 7 days after Dose 2"
Placebo;C4591001 1161 11611021;Dose 1 all-available efficacy Dose 2 all-available efficacy Evaluable efficacy (7 days)   ;Dose 1 all-available efficacy ;Dose 2 all-available efficacy ;Evaluable efficacy (7 days)   ;Data considered potentially unreliable due to lack of PI oversight identified as significant quality event; Data considered potentially unreliable due to lack of PI oversight identified as significant quality event;" Data considered potentially unreliable due to lack of PI oversight identified as significant quality event; did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1); had other important protocol deviations on or prior to 7 days after Dose 2"
Placebo;C4591001 1161 11611025;Dose 1 all-available efficacy Dose 2 all-available efficacy Evaluable efficacy (7 days)   ;Dose 1 all-available efficacy ;Dose 2 all-available efficacy ;Evaluable efficacy (7 days)   ;Data considered potentially unreliable due to lack of PI oversight identified as significant quality event; Data considered potentially unreliable due to lack of PI oversight identified as significant quality event;" Data considered potentially unreliable due to lack of PI oversight identified as significant quality event; did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1); had other important protocol deviations on or prior to 7 days after Dose 2"
Placebo;C4591001 1161 11611029;Dose 1 all-available efficacy Dose 2 all-available efficacy Evaluable efficacy (7 days)   ;Dose 1 all-available efficacy ;Dose 2 all-available efficacy ;Evaluable efficacy (7 days)   ;Data considered potentially unreliable due to lack of PI oversight identified as significant quality event; Data considered potentially unreliable due to lack of PI oversight identified as significant quality event;" Data considered potentially unreliable due to lack of PI oversight identified as significant quality event; did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1); had other important protocol deviations on or prior to 7 days after Dose 2"
Placebo;C4591001 1161 11611031;Dose 1 all-available efficacy Dose 2 all-available efficacy   Evaluable efficacy (7 days)   ;Dose 1 all-available efficacy ;Dose 2 all-available efficacy   ;Evaluable efficacy (7 days)   ;Data considered potentially unreliable due to lack of PI oversight identified as significant quality event; Data considered potentially unreliable due to lack of PI oversight identified as significant quality event;"   Data considered potentially unreliable due to lack of PI oversight identified as significant quality event; did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1); had other important protocol deviations on or prior to 7 days after Dose 2"
Placebo;C4591001 1161 11611038;Dose 1 all-available efficacy Dose 2 all-available efficacy Evaluable efficacy (7 days)   ;Dose 1 all-available efficacy ;Dose 2 all-available efficacy ;Evaluable efficacy (7 days)   ;Data considered potentially unreliable due to lack of PI oversight identified as significant quality event; Data considered potentially unreliable due to lack of PI oversight identified as significant quality event;" Data considered potentially unreliable due to lack of PI oversight identified as significant quality event; did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1); had other important protocol deviations on or prior to 7 days after Dose 2"
Placebo;C4591001 1161 11611043;Dose 1 all-available efficacy Dose 2 all-available efficacy Evaluable efficacy (7 days)   ;Dose 1 all-available efficacy ;Dose 2 all-available efficacy ;Evaluable efficacy (7 days)   ;Data considered potentially unreliable due to lack of PI oversight identified as significant quality event; Data considered potentially unreliable due to lack of PI oversight identified as significant quality event;" Data considered potentially unreliable due to lack of PI oversight identified as significant quality event; did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1); had other important protocol deviations on or prior to 7 days after Dose 2"
Placebo;C4591001 1161 11611044;Dose 1 all-available efficacy Dose 2 all-available efficacy Evaluable efficacy (7 days)     ;Dose 1 all-available efficacy ;Dose 2 all-available efficacy ;Evaluable efficacy (7 days)     ;Data considered potentially unreliable due to lack of PI oversight identified as significant quality event; Data considered potentially unreliable due to lack of PI oversight identified as significant quality event;" Data considered potentially unreliable due to lack of PI oversight identified as significant quality event; did not receive all vaccinations as randomized or did not receive Dose 2 within the   predefined window (19-42 days after Dose 1); had other important protocol deviations on or prior to 7 days after Dose 2"
Placebo;C4591001 1162 11621059;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Unblinded prior to 7 days post Dose 2;  Unblinded prior to 7 days post Dose 2; 
Placebo;C4591001 1162 11621213;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 1162 11621278;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 1162 11621297;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 1163 11631003;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Had other important protocol deviations on or prior to 7 days after Dose 2;;
Placebo;C4591001 1163 11631007;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Had other important protocol deviations on or prior to 7 days after Dose 2;;
Placebo;C4591001 1163 11631008;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1163 11631010;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Had other important protocol deviations on or prior to 7 days after Dose 2;;
Placebo;C4591001 1163 11631030;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Had other important protocol deviations on or prior to 7 days after Dose 2;;
Placebo;C4591001 1163 11631062;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Had other important protocol deviations on or prior to 7 days after Dose 2;;
Placebo;C4591001 1163 11631092;Evaluable efficacy (7 days)  ;;;Evaluable efficacy (7 days)  ;Had other important protocol deviations on or prior to 7 days after Dose 2;  ;
Placebo;C4591001 1163 11631100;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1171 11711215;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 1171 11711220;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 1171 11711222;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 1171 11711230;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 1171 11711232;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 1171 11711235;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 1171 11711244;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 1177 11771089;Evaluable efficacy (7 days)  ;;;Evaluable efficacy (7 days)  ;"Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1); had other important protocol deviations on or prior to 7 days after Dose 2";;
Placebo;C4591001 1178 11781056;Dose 1 all-available efficacy Dose 2 all-available efficacy Evaluable efficacy (7 days)   ;Dose 1 all-available efficacy ;Dose 2 all-available efficacy ;Evaluable efficacy (7 days)   ;Did not receive at least 1 vaccination;  Did not receive 2 vaccinations;"  Randomized but did not meet all eligibility criteria; did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1)"
Placebo;C4591001 1179 11791169;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1197 11971038;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 1197 11971046;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 1197 11971052;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 1204 12041057;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1213 12131023;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1214 12141011;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1219 12191052;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1219 12191055;Dose 2 all-available efficacy Evaluable efficacy (7 days)  ;Dose 2 all-available efficacy ;;Evaluable efficacy (7 days)  ;Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);  
Placebo;C4591001 1219 12191060;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1220 12201055;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Unblinded prior to 7 days post Dose 2;  Unblinded prior to 7 days post Dose 2; 
Placebo;C4591001 1220 12201058;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Unblinded prior to 7 days post Dose 2;  Unblinded prior to 7 days post Dose 2; 
Placebo;C4591001 1221 12211057;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Unblinded prior to 7 days post Dose 2;  Unblinded prior to 7 days post Dose 2; 
Placebo;C4591001 1221 12211085;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1224 12241057;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 1224 12241157;Dose 1 all-available efficacy Dose 2 all-available efficacy Evaluable efficacy (7 days)   ;Dose 1 all-available efficacy ;Dose 2 all-available efficacy ;Evaluable efficacy (7 days)   ;Did not receive at least 1 vaccination;  Did not receive 2 vaccinations;"  Randomized but did not meet all eligibility criteria; did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1)"
Placebo;C4591001 1226 12261613;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1226 12262240;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1229 12291080;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 1231 12311057;Evaluable efficacy (7 days)  ;;;Evaluable efficacy (7 days)  ;"Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1); had other important protocol deviations on or prior to 7 days after Dose 2";;
Placebo;C4591001 1231 12311549;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1231 12311672;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 1231 12311723;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1231 12311935;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1231 12311979;Evaluable efficacy (7 days)  ;;;Evaluable efficacy (7 days)  ;Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);  ;
Placebo;C4591001 1231 12312130;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1231 12312347;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 1231 12312571;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1231 12313039;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1231 12313090;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1231 12313103;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1231 12313457;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1231 12314120;Dose 2 all-available efficacy Evaluable efficacy (7 days)  ;Dose 2 all-available efficacy ;;Evaluable efficacy (7 days)  ;Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);  
Placebo;C4591001 1231 12314189;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1231 12314863;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1231 12314972;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 1231 12315608;Dose 2 all-available efficacy Evaluable efficacy (7 days) ;Dose 2 all-available efficacy ;;Evaluable efficacy (7 days) ;Did not receive 2 vaccinations;"  Randomized but did not meet all eligibility criteria; did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1)";
Placebo;C4591001 1231 12315625;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 1231 12315672;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1232 12321127;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1232 12321234;Dose 2 all-available efficacy Evaluable efficacy (7 days)  ;Dose 2 all-available efficacy ;;Evaluable efficacy (7 days)  ;Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);  
Placebo;C4591001 1232 12321242;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1232 12321281;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1241 12412568;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1247 12471066;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1247 12471135;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1247 12471166;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 1248 12481049;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 1251 12511047;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 1251 12511067;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 1251 12511078;Evaluable efficacy (7 days)  ;;;Evaluable efficacy (7 days)  ;Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);  ;
Placebo;C4591001 1260 12601030;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 1260 12601121;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1264 12641195;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 1265 12651026;Evaluable efficacy (7 days)  ;;;Evaluable efficacy (7 days)  ;"Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1); had other important protocol deviations on or prior to 7 days after Dose 2";;
Placebo;C4591001 1270 12701057;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 4444 44441152;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 4444 44442061;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 4444 44442074;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 4444 44442075;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 4444 44442096;Evaluable efficacy (7 days)  ;;;Evaluable efficacy (7 days)  ;Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);  ;
Placebo;C4591001 4444 44442108;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 4444 44442116;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 4444 44442126;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 4444 44442127;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 4444 44442132;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 4444 44442134;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 4444 44442139;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 4444 44442141;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 4444 44442150;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 4444 44442164;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 4444 44442166;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 4444 44442169;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 4444 44442179;Dose 2 all-available efficacy Evaluable efficacy (7 days);Dose 2 all-available efficacy ;;Evaluable efficacy (7 days);Did not receive 2 vaccinations;  Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);
Placebo;C4591001 4444 44442243;Evaluable efficacy (7 days) ;;;Evaluable efficacy (7 days) ;Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);  ;
Placebo;C4591001 4444 44442282;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 4444 44442290;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 4444 44442296;Evaluable efficacy (7 days);;;Evaluable efficacy (7 days);Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);;
Placebo;C4591001 4444 44442309;Evaluable efficacy (7 days)     ;;;Evaluable efficacy (7 days)     ;Did not receive all vaccinations as randomized or did not receive Dose 2 within the predefined window (19-42 days after Dose 1);     ;
